An individual may have limited or impaired mobility such that typical urination processes are challenging or impossible. For example, the individual may have surgery or a disability that impairs mobility. In another example, the individual may have restricted travel conditions such as those experience by pilots, drivers, and workers in hazardous areas. Additionally, fluid collection from the individual may be needed for monitoring purposes or clinical testing.
Bed pans and urinary catheters, such as a Foley catheter, can be used to address some of these circumstances. However, bed pans and urinary catheters have several problems associated therewith. For example, bed pans can be prone to discomfort, spills, and other hygiene issues. Urinary catheters be can be uncomfortable, painful, and can cause urinary tract infections.
Thus, users and manufacturers of fluid collection devices continue to seek new and improved devices, systems, and methods to collect urine.
Embodiments disclosed herein are related to devices, systems, and methods of using fluid collection devices. In an embodiment, a fluid collection device is disclosed. The fluid collection device includes a fluid collection member. The fluid collection member includes a fluid impermeable barrier at least partially defining a chamber, the fluid impermeable barrier also defining an opening extending therethrough, the opening configured to be positioned adjacent to a female urethra or have a male urethra positioned therethrough. The fluid collection member includes wicking material disposed at least partially within the chamber. The fluid collection member includes a conduit disposed within the chamber, the conduit including an inlet positioned within the fluid collection device and an outlet configured to be in fluid communication with a portable vacuum source. The fluid collection device includes at least one flange extending outwardly from the fluid collection member, the at least one flange including an adhesive member thereon.
In an embodiment, a fluid collection system is disclosed. The fluid collection system includes a fluid storage container configured to hold a fluid. The fluid collection system includes a fluid collection device in fluid communication with the fluid storage container. The fluid collection device includes a fluid collection member. The fluid collection member includes a fluid impermeable barrier at least partially defining a chamber, the fluid impermeable barrier also defining an opening extending therethrough, the opening configured to be positioned adjacent to a female urethra or have a male urethra positioned therethrough. The fluid collection member includes a wicking material disposed at least partially within the chamber. The fluid collection member includes a conduit disposed within the chamber, the conduit including an inlet positioned within the fluid collection device and an outlet configured to be in fluid communication with a portable vacuum source. The fluid collection device includes at least one flange extending outwardly from the fluid collection member, the at least one flange including an adhesive member thereon. The fluid collection system includes a vacuum source in fluid communication with one or more of the fluid storage container or the fluid collection device, the vacuum source configured to draw fluid from the fluid collection device.
In an embodiment, a method to collect fluid is disclosed. The method includes positioning an opening of a fluid collection device adjacent to a female urethra or around a male urethra of a user, the opening defined by a fluid impermeable barrier of the fluid collection device. The method includes positioning securing the fluid collection device to the user. The method includes positioning receiving fluid from the female urethra or male urethra into a chamber of the fluid collection device, the chamber of the fluid collection device at least partially defined by the fluid impermeable barrier.
Features from any of the disclosed embodiments may be used in combination with one another, without limitation. In addition, other features and advantages of the present disclosure will become apparent to those of ordinary skill in the art through consideration of the following detailed description and the accompanying drawings.
The drawings illustrate several embodiments of the present disclosure, wherein identical reference numerals refer to identical or similar elements or features in different views or embodiments shown in the drawings.
Embodiments disclosed herein are related to devices, systems, and methods of using fluid collection devices and systems. The devices, systems, and methods of using fluid collection devices and systems include at least one flange extending from the fluid collection device where the at least one flange is positioned to attach to the skin of a user and align the fluid collection device with one or more anatomical structures of the user (e.g., urethra). The devices, systems, and methods of using fluid collection devices and systems include a portable vacuum source to remove urine from the fluid collection device. The portable vacuum source may allow for portable usage of the systems and methods herein such as in non-hospital environments.
In an embodiment, a fluid collection device includes a fluid impermeable barrier that at least partially defines a chamber. The fluid impermeable barrier also defines an opening extending therethrough that is configured to be positioned adjacent to a female urethra or have a male urethra positioned therethrough. The fluid collection device also includes a tube having a channel extending between an inlet and outlet thereof. The inlet is configured to be coupled to a suction source and the outlet is configured to be fluidly coupled to (e.g., in fluid communication with) a fluid storage (vessel or container). The outlet is positioned downstream from the inlet. The channel also defines at least one aperture therein that fluidly couples an interior of the channel to the rest of the chamber.
The fluid collection devices disclosed herein are configured to collect fluid(s) from an individual. The fluid(s) collected by the fluid collection devices can include urine. The fluid(s) collected by the fluid collection devices can also include at least one of vagina discharge, penile discharge, reproductive fluids, blood, sweat, or other bodily fluids.
The fluid collection devices disclosed herein are configured to be used in fluid collection systems. The fluid collection systems disclosed herein include a gas source. Systems that include a gas source can, in some embodiments, resolve several problems associated with systems that include a vacuum source. For example, a system that includes a vacuum source draws fluid(s) towards the vacuum source and deposits most of the fluid(s) in a fluid storage container before the fluid(s) can reach the vacuum source. However, a small quantity of fluid(s) (e.g., vapor from the fluid) can still reach the vacuum source, which can contaminate and/or damage (e.g., rust) the vacuum source. Additionally, a large quantity of the fluid(s) can reach the vacuum source when the fluid storage container is substantially full. However, a system that includes a gas source moves the fluid(s) away from the gas source, thereby preventing contamination and/or damage. For example, a gas source may be used to create a vacuum by flowing a gas past a connected end of the conduit at a perpendicular or oblique angle to the conduit to create a vacuum in the conduit. The fluids are pulled up the conduit and into the gas flow in the direction of the gas flow, which is away from the gas source. In another embodiment, systems that include a vacuum source cannot be used in environments that do not include an available vacuum source (e.g., the environment does not include a vacuum source or the vacuum source is being used). As such, systems that include a gas source can be used in environments that do not include an available vacuum source. A liquid source can be used to create and implement a vacuum in the same way as the gas source. The vacuum source or gas source can be utilized with any of the devices or systems disclosed herein to remove a fluid therefrom.
The suction force may be applied indirectly via the fluid storage container 14. For example, the second open end of the conduit 17 may be disposed within the fluid storage container 14 and an additional conduit 17 may extend from the fluid storage container 14 to the vacuum source 16. Accordingly, the vacuum source 16 may apply suction to the fluid collection device 12 via the fluid storage container 14. The suction force may be applied directly via the fluid storage container 14. For example, the second open end of the conduit 17 may be disposed within the vacuum source 16. An additional conduit 17 may extend from the vacuum source 16 to a point outside of the fluid collection device 12, such as to the fluid storage container 14. In such examples, the vacuum source 16 may be disposed between the fluid collection device 12 and the fluid storage container 14.
The fluid collection device 12 may be shaped and sized to be positioned adjacent to a female urethra. For example and as described in more detail below, the fluid collection device 12 may include a fluid collection member and at least one flange positioned and equipped to attach to the skin of a user and align the fluid collection member in a selected portion of the anatomy of the user (e.g., adjacent to or on the urethra or vagina). For example, the at least one flange may include an adhesive for reversibly attaching to the skin of the user and may be positioned on the fluid collection member to align an opening of the fluid collection member with the vagina (e.g., on or over the urethra or between the labia) of a female user.
The fluid collection member of the fluid collection device 12 may include a fluid impermeable barrier at least partially defining a chamber (e.g., interior region of the fluid collection device member) of the fluid collection device 12. The fluid impermeable barrier also defines an opening extending therethrough from the external environment. The opening may be positioned on the fluid collection member to be aligned adjacent to a female urethra. The fluid collection member of the fluid collection device 12 may include a fluid permeable membrane disposed within the fluid impermeable barrier. The fluid collection member of the fluid collection device 12 may include a fluid permeable support disposed within the fluid permeable membrane. The conduit 17 may extend into the fluid collection device 12 at a first end region, through one or more of the fluid impermeable barrier, fluid permeable membrane, or the fluid permeable support to a second end region of the fluid collection member of the fluid collection device 12. Exemplary fluid collection devices for use with the systems and methods herein are described in more detail below.
In examples, the fluid storage container 14 may include a bag (e.g., drainage bag), a bottle or cup (e.g., collection jar), or any other enclosed container for storing bodily fluid(s) such as urine. In examples, the conduit 17 may extend from the fluid collection device 12 and attach to the fluid storage container 14 at a first point therein. An additional conduit 17 may attach to the fluid storage container 14 at a second point thereon and may extend and attach to the vacuum source 16. For example, the fluid storage container 14 may include a container in fluid communication with a first conduit section that is also in fluid communication with the fluid collection member of the fluid collection device 12. The container may be in fluid communication with a second section of the conduit 17 that is also in fluid communication with a vacuum source. In such examples, the vacuum source 16 may provide a vacuum/suction through the container to the fluid collection member to provide suction in the chamber of the fluid collection member. Accordingly, a vacuum (e.g., suction) may be drawn through fluid collection device 12 via the fluid storage container 14. As the fluid is drained from the chamber, the fluid may travel through the first section of conduit to the fluid storage container where it may be retained. Fluid, such as urine, may be drained from the fluid collection device 12 using the vacuum source 16.
In some examples, the vacuum source 16 may include a portable vacuum source. In examples, the portable vacuum source may be disposed in or on the fluid collection device 12. In such examples, the conduit 17 may extend from the fluid collection device and attach to the (portable) vacuum source 16 at a first point therein. An additional conduit 17 may attach to the vacuum source 16 at a second point thereon and may extend out of the fluid collection device 12, and may attach to the fluid storage container 14. Accordingly, a vacuum (e.g., suction) may be drawn through fluid collection device 12 via the fluid storage container 14.
The vacuum source 16 may include one or more of a vacuum line plumbed into patient care facility, a manual vacuum pump, and electric vacuum pump, a diaphragm pump, a centrifugal pump, a displacement pump, a magnetically driven pump, a peristaltic pump, or any pump configured to produce a vacuum. The vacuum source 16 may provide a vacuum or suction to remove fluid from the fluid collection member of the fluid collection device 12. In examples, the vacuum source 16 may be powered by one or more of a power cord (e.g., connected to a power socket), one or more batteries, or even manual power (e.g., a hand operated vacuum pump). In examples, the vacuum source 16 (e.g., portable vacuum source) may be sized and shaped to fit outside of, on, or within the fluid collection device 12. For example, the vacuum source 16 (e.g., portable vacuum source) may include one or more miniaturized pumps or one or more micro pumps. The vacuum sources 16 disclosed herein may include one or more of a switch, a button, a plug, a remote, or any other device suitable to activate the vacuum source 16. It should be understood that the vacuum sources 16 disclosed herein may provide a portable means of providing a suction or vacuum that allows use of the devices and systems herein outside of hospital or care facility environments where vacuum lines are plumbed into patient rooms or large (e.g., larger or heavier than a patient can readily carry) vacuum sources are located. For example, a portable vacuum source may be small and light enough to be carried by a user (e.g., patient) or aid (e.g., nurse) during transportation of the user.
The fluid impermeable barrier 102 at least partially defines at least a portion of an outer surface of the fluid collection member 101. The fluid impermeable barrier 102 at least partially defines a chamber 104 therein (e.g., interior region of the fluid collection member 101) and an opening 106. The opening 106 is formed in and extends through the fluid impermeable barrier 102, thereby enabling fluid(s) to enter the chamber 104 from outside of the fluid collection member 101 of the fluid collection device 100. The opening 106 can be configured to be positioned adjacent to a female urethra, such as between the labia majora of a female user.
The fluid impermeable barrier 102 may also temporarily retain or store fluid(s) in the chamber 104. For example, the fluid impermeable barrier 102 can be formed of any suitable fluid impermeable materials, such as a fluid impermeable polymer (e.g., silicone, polypropylene, polyethylene, polyethylene terephthalate, polyurethane, a polycarbonate, polyvinyl chloride, latex, silicone, etc.), a metal film, another suitable material, or combinations thereof. As such, the fluid impermeable barrier 102 may prevent at least some of the fluid(s) from exiting the portions of the chamber 104 that are spaced from the opening 106.
In an embodiment, the fluid impermeable barrier 102 can be air permeable and fluid impermeable. In such an embodiment, the fluid impermeable barrier 102 can be formed of a hydrophobic material that defines a plurality of pores. In an example, one or more portions of at least an outer surface of the fluid impermeable barrier 102 can be formed from a soft and/or smooth material thereby reducing chafing of the skin of the user. The fluid impermeable barrier 102 may include markings thereon, such as one or more markings to aid a user in aligning the device 100 on the wearer. For example, a line on the fluid impermeable barrier 102 (e.g., opposite the opening 106) may allow a healthcare professional to align the opening 106 over the urethra of the wearer. In examples, the markings may include one or more of alignment guide or an orientation indicator, such as a stripe or hashes. Such markings may be positioned to align the device 100 to one or more anatomical features such as a pubic bone, etc.
The wicking material 115 may be disposed at least partially within the fluid impermeable barrier 102. The wicking material 115 may include permeable material designed to wick or allow fluid to pass therethrough. The permeable properties referred to herein can be wicking, capillary action, diffusion, or other similar properties or processes, and are referred to herein as “permeable” and/or “wicking.” Such “wicking” may not include absorption into the wicking material. The wicking material 115 may collect the fluid that travels through the opening 106. The wicking material 115 may include more than one material, such as a plurality of materials. The plurality of materials may include a plurality of layers concentrically disposed within one another. The concentrically disposed layers of wicking materials may exhibit a gradient of wicking, such as where the innermost wicking material includes the greatest or least wicking ability of the plurality of materials.
In examples, the wicking material 115 may include one or more of a fluid permeable support (
The fluid collection device 100 can include a fluid permeable support 120 (
In some embodiments, the wicking material 115 (e.g., one or more of the fluid permeable membrane 118 or the fluid permeable support) can at least substantially completely fill portions of the chamber 104 that are not occupied by the conduit 108. For example, the wicking material 115 may fill the portions of the chamber 104 that are not occupied by the conduit 108. In some examples, the fluid permeable membrane 118 and the fluid permeable support may not substantially completely fill the portions of the chamber 104 that are not occupied by the conduit 108. In such examples, the fluid collection device 100 may include the reservoir (e.g., void space) disposed in the chamber 104. The reservoir may include a void space between the wicking material in the chamber 104 and the interior surface of the fluid impermeable barrier 102. At least some of the fluid absorbed by the wicking material 115 may drain out of the wicking material 115 and collect in the reservoir.
The fluid collection member 101 of the fluid collection device 100 may also include conduit 108 that is at least partially disposed in the chamber 104. The conduit 108 may include a flexible material such as plastic tubing (e.g., medical tubing). Such plastic tubing may include a thermoplastic elastomer, polyvinyl chloride, ethylene vinyl acetate, polytetrafluoroethylene, etc., tubing. In examples, the conduit 108 may include silicon or latex. The conduit 108 (e.g., a tube) includes an inlet at a first end region and an outlet at a second end region positioned downstream from the inlet. The conduit 108 places an interior region of the chamber 104 in fluid communication with one or more of the fluid storage container (
In examples, the conduit 108 may be disposed in an innermost or gravimetrically low spot in the chamber 104. For example, the conduit 108 may extend far enough into the chamber 104 to position the inlet in a gravimetrically low spot of the chamber 104 (e.g., fluid reservoir within the interior of the fluid collection member 101).
The fluid collection member 101 and components thereof may be deformable (e.g., bendable) responsive to pressure applied thereto. For example, the fluid collection member 101 and the components thereof may bend to conform to the surface of the user, such as when disposed between a garment and the user. In examples, the fluid collection member 101 may bend when disposing proximate to the urethra (e.g., between the labia) when undergarments are pulled on over the fluid collection member 101.
The at least one flange 140 may extend from the fluid collection member 101. The at least one flange may include a flange body 142 and an adhesive member 144 disposed on the flange body 142. In some examples, the at least one flange 140 may include 2 or more flanges (e.g., 4 flanges). The at least one flange 140 may include a first flange body extending a first direction away from the fluid collection member 101 and a second flange body extending away from the fluid collection member 101 in a second direction, wherein the first and second directions are substantially opposite one another (e.g., at least 120° apart). The at least one flange 140 may extend along at least a portion of the longitudinal length of fluid collection member 101. For example, the at least one flange 140 may have a width, as viewed parallel to the plane B-B, of least 5% (e.g., at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, or less than 60%) of the longitudinal length of the fluid collection member 101. In examples, the width of the flange 140 may be at least 1 cm, such as 2 cm, 5 cm, 10 cm, 15 cm, 20 cm, 30 cm, or in a range between any combination of the foregoing. The flange 140 (e.g., flange body 142) may extend at least 1 cm away from the fluid collection member 101, such as 1 cm, 3 cm, 5 cm, 10 cm, 15 cm, 20 cm, 25 cm, 30 cm, or in a range between any combination of the foregoing, away from the fluid collection member 101.
In examples, the flange body 142 of the at least one flange 140 may be formed of the same material as the fluid impermeable barrier 102. In examples, the flange body 142 of the at least one flange 140 may be formed from one or more of cloth, paper, plastic, or any other material suitable for deforming responsive to pressure applied thereto and able to withstand moisture without breaking down. For example, the flange body 142 may be formed from thermoplastic elastomer, polyethylene, polyvinyl chloride, ethylene vinyl acetate, polytetrafluoroethylene, latex, silicon, fabric, woven cloth, etc. In examples, the conduit 108 may include silicon or latex. The flange body 142 of the at least one flange 140 may be flexible and may conform to manipulation or movement by a user. The flange body 142 may exhibit any of the dimensions disclosed above for the flange 140.
The flange body 142 may have the adhesive member 144 disposed thereon, such as at a distal portion thereof (e.g., distal from the fluid collection member 101). The adhesive member 144 may be affixed to the flange body 142 by mechanical means such as a staple(s), a clip, hook and loop fasteners, etc.; may be affixed by an adhesive; or may be integrally formed in the flange body 142. The adhesive member 144 may be positioned on the flange body 142 in a position effective to allow the adhesive to be applied to a garment of the skin of the user to maintain a position of the fluid collection member 101 with respect to one or more anatomical features (e.g., proximate to the female urethra or between the labia) of the user. For example, the adhesive member 144 may be positioned on the flange body 142 to allow the at least one flange(s) 140 to adhere to the inner thigh of a user and maintain a position of the associated fluid collection member 101 between the labia of the user 190. In examples, the adhesive member 144 may be flexible or otherwise configured to conform to the anatomical features of the user and accommodate movement of the user.
Returning to
In examples, the adhesive member 144 may include a glue, contact adhesive, epoxy, hydrogel adhesive, tape, or other adhesive suitable for attaching the flange to skin or fabric. For example, the adhesive may include an acrylate (e.g., methacrylate or epoxy diacrylate) or any other adhesive suitable for use on bandages.
The cross-sectional profiles of the fluid collection devices disclosed herein may vary. For example, a longitudinal cross section is taken along the plane A-A and an axial cross section may be viewed along the plane B-B in
In the illustrated embodiment, the conduit 108 is at least partially disposed in the chamber 104. For example, the conduit 108 may extend into the fluid impermeable barrier 102 from the first end region (e.g., proximate to the outlet 112) and may extend to the second end region (e.g., opposite the first end region) to a point proximate to the reservoir 122 such that the inlet 110 is in fluid communication with the reservoir 122. The fluid collected in the fluid collection member 101 may be removed from the interior region of the chamber 104 via the conduit 108. The conduit 108 may include a flexible material such as plastic tubing (e.g., medical tubing) as disclosed herein. In some examples, the conduit 108 may include one or more portions that are resilient, such as to by having one or more of a diameter or wall thickness that allows the conduit to be flexible.
The fluid collection member 101 may be positioned proximate to the female urethra (e.g., on or between the labia) and urine may enter the chamber 104 of the fluid collection member 101 via the opening 106. The fluid collection member 101 receives the fluid(s) into the chamber 104 via the opening 106. For example, the opening 106 can exhibit an elongated shape that is sized and positioned to extend from a first location below the urethral opening (e.g., at or near the anus or the vaginal opening) to a second location above the urethral opening (e.g., at or near the clitoris or the mons pubis). The opening 106 can exhibit an elongated shape since the space between the legs of a female is relatively small when the legs of the female of closed thereby only permitting the flow of the fluid(s) along a path that corresponds to the elongated shape of the opening 106. The longitudinal axis or dimension of the fluid collection device refers to the axis or dimension that is parallel to largest dimension of the device, such as axially along a cylindrical device as show in
The fluid collection member 101 includes the wicking material 115 disposed in the chamber 104. The wicking material 115 may include one or more of the fluid permeable membrane 118 and the fluid permeable support 120, each disposed in the chamber 104. The fluid permeable membrane 118 can cover at least a portion (e.g., all) of the opening 106. The fluid permeable membrane 118 can be configured to wick any fluid away from the opening 106 thereby preventing the fluid from escaping the chamber 104. The fluid permeable membrane 118 can also wick the fluid generally towards an interior of the chamber 104, as discussed in more detail below. The fluid permeable membrane 118 can include any material that can wick the fluid. For example, the fluid permeable membrane 118 can include fabric, such as a gauze (e.g., a silk, linen, polymer based materials such as polyester, or cotton gauze), another soft fabric, or another smooth fabric. Forming the fluid permeable membrane 118 from gauze, soft fabric, and/or smooth fabric can reduce chafing caused by the fluid collection member 101.
The fluid permeable support 120 may be disposed in the chamber 104, such as concentrically within the fluid permeable membrane 118. The fluid permeable support 120 may be formed from material that is more rigid (e.g., less deformable) than the fluid permeable membrane 118, such as any of the materials disposed herein for a fluid permeable membrane. For example, the fluid permeable support 120 can include a porous nylon structure. The fluid permeable support 120 is configured to support the fluid permeable membrane 118 since the fluid permeable membrane 118 can be formed from a foldable, flimsy, or otherwise easily deformable material. For example, the fluid permeable support 120 can be positioned such that the fluid permeable membrane 118 is disposed between the fluid permeable support 120 and the fluid impermeable barrier 102. As such, the fluid permeable support 120 can support and maintain the position of the fluid permeable membrane 118. In an embodiment, the fluid permeable support 120 can be omitted from the fluid collection member 101.
In an embodiment, the fluid permeable membrane 118 and the fluid permeable support 120 can at least substantially completely fill the portions of the chamber 104 that are not occupied by the conduit 108. In another example, the fluid permeable membrane 118 and the fluid permeable support 120 may not substantially completely fill the portions of the chamber 104 that are not occupied by the conduit 108. In such an example, the fluid collection device 100 includes the reservoir 122 disposed in the chamber 104. The reservoir 122 is a substantially unoccupied portion of the chamber 104. The fluid(s) that is in the chamber 104 can flow through the fluid permeable membrane 118 and/or fluid permeable support 120 to the reservoir 122. The reservoir 122 can store at least some of the fluid(s) therein.
The fluid impermeable barrier 102 can store fluid(s) in the reservoir 122. The reservoir 122 may be disposed in any portion of the interior region of the chamber 104. For example, the fluid reservoir 122 may be positioned in the second end region of the chamber 104.
In an example, the reservoir 122 can be located at the portion of the chamber 104 that is closest to the inlet 110 (e.g., the second end region). However, the reservoir 122 can be located at different locations in the chamber 104. For example, the reservoir 122 can be located at the end of the chamber 104 that is closest to the outlet 112. In another example, fluid collection device 100 can include multiple reservoirs, such as a first reservoir that is located at the portion of the chamber of the chamber 104 that is closest to the inlet 110 (e.g., second end region) and a second reservoir that is located at the portion of the of the chamber 104 that is closest to the outlet 112 (e.g., first end region). In another example, the fluid permeable support 120 is spaced from at least a portion of the conduit 108 and the reservoir 122 can be the space between the fluid permeable support 120 and the conduit 108.
Other examples of fluid impermeable barriers, fluid permeable membranes, fluid permeable supports, chambers, and their shapes and configurations are disclosed in U.S. patent application Ser. No. 15/611,587 filed on Jun. 1, 2017 and U.S. patent application Ser. No. 15/260,103 filed on Sep. 8, 2016 (published as US 2016-0374848 on Dec. 29, 2016), the disclosure of each of which is incorporated herein, in its entirety, by this reference.
The fluid impermeable barrier 102, the fluid permeable membrane 118 and the fluid permeable support 120 can be configured to have the conduit 108 at least partially disposed in the chamber 104. For example, at least one of the fluid permeable membrane 118 and the fluid permeable support 120 can be configured to form a space that accommodates the conduit 108. In another example, the fluid impermeable barrier 102 can define an aperture 124 sized to receive the conduit 108 (e.g., at least one tube). The at least one conduit 108 can be disposed in the chamber 104 via the aperture 124 in the first end region of the device 100. The aperture 124 can be configured to form an at least substantially fluid tight seal against the conduit 108 or the at least one tube thereby substantially preventing the fluid(s) from escaping the chamber 104. In some embodiments, the aperture 124 may be disposed on the second end region nearer the reservoir 122. In such embodiments, the conduit 108 may be disposed in only the second end region with the inlet 110 being disposed in the second end region (e.g., the reservoir 122).
As previously discussed, the conduit 108 is configured to be coupled to, and at least partially extend between, one or more of the fluid storage container (not shown) and the vacuum source (not shown). In an example, the conduit 108 is configured to be directly connected to the vacuum source (not shown). In such an example, the conduit 108 can extend from the fluid impermeable barrier 102 by at least one foot, at least two feet, at least three feet, or at least six feet. In another example, the conduit 108 is configured to be indirectly connected to at least one of the fluid storage container (not shown) and the vacuum source (not shown). In some embodiments, the conduit is secured to a wearer's skin with a catheter securement device, such as a STATLOCK® catheter securement device available from C. R. Bard, Inc., including but not limited to those disclosed in U.S. Pat. Nos. 6,117,163; 6,123,398; and 8,211,063, the disclosures of which are all incorporated herein by reference in their entirety.
The inlet 110 and the outlet 112 are sized, positioned, or otherwise configured to place (e.g., directly or indirectly) the vacuum source (not shown) in fluid communication with the chamber 104 (e.g., the reservoir 122). In an example, the inlet 110 and/or the outlet 112 can form a male connector. In another example, the inlet 110 and/or the outlet 112 can form a female connector. In an example, the inlet 110 and/or the outlet 112 can include ribs that are configured to facilitate secure couplings. In an example, the inlet 110 and/or the outlet 112 can form a tapered shape. In an example, the inlet 110 and/or the outlet 112 can include a rigid or flexible material.
Locating the inlet 110 at or near a gravimetrically low point of the chamber 104 enables the conduit to receive more of the fluid(s) than if inlet 110 was located elsewhere and reduce the likelihood of pooling (e.g., pooling of the fluid(s) can cause microbe growth and foul odors). For instance, the fluid(s) in the fluid permeable membrane 118 and the fluid permeable support 120 can flow in any direction due to capillary forces. However, the fluid(s) may exhibit a preference to flow in the direction of gravity, especially when at least a portion of the fluid permeable membrane 118 and/or the fluid permeable support 120 is saturated with the fluid(s).
As the vacuum source (
In an example, the conduit 108 is configured to be at least insertable into the chamber 104. In such an example, the conduit 108 can include one or more markers (not shown) on an exterior thereof that are configure to facilitate insertion of the conduit 108 into the chamber 104. For example, the conduit 108 can include one or more markings thereon that are configured to prevent over or under insertion of the conduit 108, such as when the conduit 108 defines an inlet 110 configured to be disposed in or adjacent to the reservoir 122. In another example, the conduit 108 can include one or more markings thereon that are configured to facilitate correct rotation of the conduit 108 relative to the chamber 104. In an example, the one or more markings can include a line, a dot, a sticker, or any other suitable marking. In some examples, the conduit may be frosted or opaque (e.g., black) to obscure visibility of the fluid(s) therein.
In an example, one or more components of the fluid collection device 100 can include an antimicrobial material, such as an antibacterial material where the fluid collection device may contact the wearer or the bodily fluid of the wearer. The antimicrobial material can include an antimicrobial coating, such as a nitrofurazone or silver coating. The antimicrobial material can inhibit microbial growth, such as microbial growth due to pooling or stagnation of the fluid(s). In an example, one or more components (e.g., impermeable barrier 102, conduit 108, etc.) of the fluid collection device 100 can include an odor blocking or absorbing material such as a cyclodextrine containing material or a thermoplastic elastomer (TPE) polymer.
The at least one flange 140 can be disposed on a lower portion of the fluid collection member 101 (e.g., substantially opposite the opening 106). For example, the at least one flange 140 may extend from the fluid collection member 101 may have the at least one flange 140 affixed to or integrally formed in the fluid impermeable barrier 102.
The fluid collection device 400 includes the conduit 108 that is at least partially disposed in the chamber 104. For example, the wicking material 115 (e.g., the fluid permeable membrane 118, the fluid permeable support 120) may fill a portion of the chamber 104 and leave a portion vacant thereby forming the reservoir 122 between the wicking material 115 and the fluid impermeable barrier 102. The conduit 108 can include one or more walls that define an inlet 110 and the outlet 112. The inlet 110 enables at least some of the fluid(s) that is present in the chamber 104 to enter the conduit 108. In an example, the conduit 108 can be configured to have the inlet 110 located at, near, or spaced at a gravimetrically low point of the chamber 104. In an example, the conduit 108 can be configured to have the at least one inlet 110 disposed in or adjacent to the reservoir 122. As shown the conduit 108 can extend through at least a portion of the chamber 104, such as longitudinally through at least a portion of the wicking material 115 in a concentrically central region fluid collection member 115.
The conduit 108 can be in fluid communication with the interior region (e.g., reservoir 122) of the chamber 104 via the fluid impermeable barrier 102. As such, the fluid impermeable barrier 102 can define the aperture 124. In an example, as illustrated, the aperture 124 enables the conduit 108 to extend outwardly from the chamber 104 when the conduit 108 is only partially disposed in the chamber 104. In examples, the conduit 108 may include a plurality of separate sections. For example and as shown, the conduit 108 may include a first section A and section B. The first section A may include the inlet 110 extending from the distal end (e.g., first end region) to the portable vacuum source 330 and the B section may extend from the portable vacuum source 330 out of the aperture 124, such as to a fluid storage container (not shown).
The portable vacuum source 330 may include any of the portable vacuum pumps disclosed herein. For example, the portable vacuum source 330 may include a manual vacuum pump, a diaphragm pump, a centrifugal pump, a displacement pump, a magnetically driven pump, a peristaltic pump, or any pump configured to produce a vacuum. The portable vacuum source 330 may be sized to fit in the chamber 104 inside of the fluid impermeable barrier 102. In examples, the portable vacuum source 330 may sealed in a fluid tight housing or container. The portable vacuum source 330 may apply a vacuum (e.g., suction) in the A section of the conduit 108 effective to suction fluid from the chamber 104. The fluid may travel through the A section to the B section (e.g., through the portable vacuum source 330) and out of the fluid collection device 300 via the B section by flow induced by the vacuum or suction applied by the portable vacuum source 330. For example, the portable vacuum source 330 may include a centrifugal pump and an impeller therein may draw the fluid from the chamber 104 via the inlet 110 and force the fluid out of the chamber 104 via the B section of the conduit 108. Each of the A section and the B section of the conduit 108 may be in fluid communication with (e.g., sealed) the portable vacuum source 330. In some examples, the portable vacuum source 330 and the conduit 108 can be integrally formed together (e.g., exhibit single piece construction).
The fluid collection device 500 includes the conduit 108 that is at least partially disposed within the fluid collection member 501. For example, the wicking material 115 (e.g., the fluid permeable membrane 118, the fluid permeable support 120) may fill a portion of the chamber 104 and leave a portion vacant thereby forming the reservoir 122 between the wicking material 115 and the fluid impermeable barrier 102. As shown the conduit 108 can extend through at least a portion of the chamber 104, such as longitudinally through at least a portion of the wicking material 115 in a concentrically central region fluid collection member 115 to the reservoir 122. The conduit 108 may extend through the wicking material 115 to the reservoir 122. The conduit 108 can include one or more walls that define an inlet 110 and the outlet 112. The inlet 110 enables at least some of the fluid(s) that is present in the chamber 104 to enter the conduit 108. In an example, the conduit 108 can be configured to have the inlet 110 located at, near, or spaced at a gravimetrically low point of the chamber 104. In an example, the conduit 108 can be configured to have the at least one inlet 110 disposed in or adjacent to the reservoir 122.
The conduit 108 can be in fluid communication with the interior region of the chamber 104 via the fluid impermeable barrier 102. As such, the fluid impermeable barrier 102 can define the aperture 124. In an example, as illustrated, the aperture 124 enables the conduit 108 to extend outwardly from the chamber 104 when the conduit 108 is only partially disposed in the chamber 104. In examples, the conduit 108 may include a plurality of separate sections. For example and as shown, the conduit 108 may include the first section A and the second section B. The first section A may include the inlet 110 extending from the distal end (e.g., first end region), out of the aperture 124, to the portable vacuum source 330 mounted thereto. The portable vacuum source 330 may be mounted to the outer surface of the fluid collection device 400. The B section may be attached to and extend from the portable vacuum source 330, such as to a fluid storage container (not shown).
The portable vacuum source 330 may include any of the portable vacuum pumps disclosed herein such as a manual vacuum pump, a diaphragm pump, a centrifugal pump, a displacement pump, a magnetically driven pump, a peristaltic pump, or any pump configured to produce a vacuum. The portable vacuum source 330 may be sized to fit in the chamber 104 inside of the fluid impermeable barrier 102. In examples, the portable vacuum source 330 may sealed in a fluid tight housing or container. The portable vacuum source 330 may apply a vacuum (e.g., suction) in the A section of the conduit 108 effective to suction fluid from the chamber 104. The fluid may travel through the A section out of the fluid collection device 400 to the portable vacuum source 330. The fluid may be removed from the portable vacuum source 330 via the B section by flow induced by the vacuum or suction applied by the portable vacuum source 330. For example, the portable vacuum source 330 may include a centrifugal pump and an impeller therein may draw the fluid from the chamber 104 via the inlet 110 and suction the fluid out of the chamber 104 via the portable vacuum source 330 to the B section of the conduit 108. Each of the A section and the B section of the conduit 108 may be in fluid communication with (e.g., sealed) the portable vacuum source 330. In some examples, the portable vacuum source 330 and the conduit 108 (e.g., one or both of the A section or the B section) can be integrally formed together to exhibit single piece construction.
The fluid collection devices shown in
In an example, at least one of portion of the conduit 108 of the fluid collection devices or systems herein can be formed of an at least partially opaque material which can obscure the fluid(s) that is present therein. For example, the B section of the conduits 108 disclosed herein may be formed of an opaque material or translucent material while the A section may be formed of a transparent material or translucent material. In examples, the B section may include transparent or translucent material. Unlike the opaque or nearly opaque material, the translucent material allows a user of the devices and systems herein to visually identify fluid(s) or issues that are inhibiting the flow of fluid(s) within the conduit 108.
In any of the example, systems or devices disclosed herein, the system of fluid collection device may include moisture sensors (not shown) disposed inside of the chamber of the fluid collection device. In such examples, the moisture sensor may be operably coupled to a controller or directly to the vacuum source, and may provide electrical signals indicating that moisture is or is not detected in one or more portions of the chamber. The moisture sensor(s) may provide an indication that moisture is present, and responsive thereto, the controller of the vacuum source (e.g., vacuum device with a programmable controller) may direct the initiation of suction to the chamber to remove the fluid therefrom. Suitable moisture sensors may include capacitance sensors, volumetric sensors, potential sensors, resistance sensors, frequency domain reflectometry sensors, time domain reflectometry sensors, or any other suitable moisture sensor. In practice, the moisture sensors may detect moisture in the chamber and may provide a signal to the controller of the vacuum source to activate the vacuum source.
As noted above, the at least one flange 140 (e.g., pair of flanges) may be positioned on the fluid collection member in any of a number of positions and may extend therefrom at any angle. The cross-sectional shape of the fluid collection members disclosed herein may include any of various shapes or sizes. For example, the cross-sectional shape (along the plane B-B of
The at least one flange 140 may extend substantially tangentially from the fluid collection member 101 (e.g., the fluid impermeable barrier 102). For example, the at least one flange 140 may include at least 2 flanges 140, each extending from the fluid collection member 101 tangentially in substantially opposite directions from one another. “Substantially tangentially” may include flanges 140 that extend outwardly at an angle within 10% of 0° from an attachment point of the flange(s) on the outer surface of the fluid impermeable barrier. In examples, the at least one flange 140 may attach to the fluid collection member 101 at a point substantially opposite the opening 106. The fluid collection member 101 may extend toward the user past the flanges 140. Such arrangements may allow the fluid collection member 101 to be positioned on the region of the female urethra, such as on or between the labia.
In examples, the flange bodies 142 may have the adhesive member 144 bound thereto on a surface thereof that generally faces the same direction as the opening 106. In some examples, the flanges 140 may alternatively or additionally include adhesive members 144 on the surface of the flange body 142 that face generally away from the opening 106. The adhesive members 144 may allow the flange body 142 to be attached (e.g., temporarily adhered) to one or more skin surfaces of the subject that are adjacent to the urethra of the user, such as the thighs or pubic region. The adhesive members 144 may secure and maintain the fluid collection device 100 in a position to collect fluid from the user, such as between the labia to collect urine from a female subject.
The at least one flange 140 may extend substantially perpendicularly away from the fluid collection member 101 (e.g., the fluid impermeable barrier 102). For example, the at least one flange 140 may include at least 2 flanges 140, each extending from the fluid collection member 101 perpendicularly (e.g., in a radial direction) from the fluid impermeable barrier 102 and in substantially opposite directions from one another. “Substantially perpendicularly” may include flanges 140 that extend outwardly at an angle within 10% of 90° with respect to an outer surface of the fluid impermeable barrier at attachment point of the flange(s) 140 thereon. For examples and as shown, the at least one flange 140 may attach to the fluid collection member 101 and radially extend therefrom in radially opposite directions. The fluid collection member 101 may extend toward the user past the flanges 140. Such arrangements may allow the fluid collection member 101 to be positioned on the region of the female urethra, such as on or between the labia.
In examples, the flange bodies 142 may have the adhesive member 144 bound thereto on a surface thereof that generally faces the same direction as the opening 106. In some examples, the flanges 140 may alternatively or additionally include adhesive members 144 on the surface of the flange body 142 that face generally away from the opening 106. The adhesive members 144 may allow the flange body 142 to be attached (e.g., temporarily adhered) to one or more skin surfaces of the subject that are adjacent to the urethra of the user, such as the thighs or pubic region. The adhesive members 144 may secure and maintain the fluid collection device 100 in a position to collect fluid from the user, such as between the labia to collect urine from a female subject.
The cross-sectional shape of the fluid collection member and the position(s) of the components therein may vary.
Additional or alternative shapes for the fluid collection members are considered. For example, the fluid collection member may have a substantially triangular cross-sectional shape where a corner or apex of the triangle faces the user.
The at least one flange 140 may extend substantially perpendicularly away from the fluid collection member 801 (e.g., the fluid impermeable barrier 102). For example, the at least one flange 140 may include at least 2 flanges 140, each extending from the fluid collection member 801 perpendicularly from the fluid impermeable barrier 102 and in substantially opposite directions from one another. For examples and as shown, the at least one flange 140 may attach to the fluid collection member 801 in radially opposite directions. The fluid collection member 801 may extend toward the user past the flanges 140. Such arrangements may allow the fluid collection member 801 to be positioned on the region of the female urethra, such as on or between the labia.
In examples, the flange bodies 142 may have the adhesive member 144 bound thereto on a surface thereof that generally faces the same direction as the opening 106. In some examples, the flanges 140 may alternatively or additionally include adhesive members 144 on the surface of the flange body 142 that face generally away from the opening 106. The adhesive members 144 may allow the flange body 142 to be attached (e.g., temporarily adhered) to one or more skin surfaces of the subject that are adjacent to the urethra of the user, such as the thighs or pubic region. The adhesive members 144 may secure and maintain the fluid collection device 100 in a position to collect fluid from the user, such as between the labia to collect urine from a female subject.
In some examples, the fluid collection devices herein may include more than one conduit therein. the more than one conduit may be disposed in a plurality of regions therein. In examples, conduit 108 may include a plurality of inlets.
Fluid collection devices having flanges thereon may be configured for use with male users. Devices and methods described herein can be configured to collect urine from a male user, such as having a fluid collection device shaped and sized to receive a male urethra (e.g., penis) therein.
Referring to
The flange(s) 940 may be similar or identical to the flange 140 disclosed herein, in one or more aspects. For example, the flange 940 may include the flange body 942 and an adhesive 944 (or other attachment body for attaching the flange body 942 to a subject or clothes of the subject). The flange body 942 may be similar or identical to the flange body 142 disclosed herein, in one or more aspects. For example, the flange body 942 may be formed from a thermoplastic elastomer, polyethylene, polyvinyl chloride, ethylene vinyl acetate, polytetrafluoroethylene, latex, silicon, fabric, woven cloth, etc. The flange body 942 may extend substantially perpendicularly to the lip 960. The adhesive 944 may be similar or identical to the adhesive 144 disclosed herein, in one or more aspects. In some examples, the more than two flanges 940 may extend from the annular base 954. In some examples (not shown), the flange 940 may include a single flange body 942 that extends from and around substantially all of the annular base 954. In such examples, the adhesive 944 may be located at discrete points or around substantially all of the surface of the flange body 942 that is expected to contact the wearer. One or more portions of the receptacle 950 may be formed from the same material as the fluid impermeable barrier 102 such as a fluid impermeable polymer (e.g., silicone, polypropylene, polyethylene, polyethylene terephthalate, polyurethane, a polycarbonate, polyvinyl chloride, latex, silicone, etc.), a metal film, another suitable material, or combinations thereof.
In an example, the annular base 954 can exhibit the general shape of the skin surface that the annular base 954 is selected to be coupled with and/or can be flexible thereby allowing the annular base 954 to conform to any shape of the skin surface. The receptacle 950 also defines a hollowed region that is configured to receive (e.g., seal against) the cup portion 952. For example, the receptacle 950 can include the lip 960 that extends upwardly from the annular base 954. The lip 960 may be tall enough to prevent the cup portion 952 from being accidentally removed from the receptacle 950 (e.g., at least 0.5 cm tall, 1 cm tall, at least 2 cm tall, or at least 5 cm tall). In some examples, the annular base 954 is optional. For example, the receptacle 950 may only include the flange 954. In some examples (not shown), the fluid collection device may have a one piece design, with the cup portion 952 and the receptacle 950 being a single piece. In some examples, the receptacle 950 is optional.
The cup portion 952 includes (e.g., may be formed from) a fluid impermeable barrier 902 that is sized and shaped to fit into the hollowed region of the receptacle 950. The cup portion 952 may be shaped to retain a fluid therein. For example, the fluid impermeable barrier 902 may define the cup portion 952, such as a substantially tubular (e.g., cylindrical) body having an enclosed end as illustrated in
The fluid collection device 900 may include wicking material therein. The fluid collection device 900 may include the fluid permeable membrane 118. The fluid permeable membrane 118 may be disposed between the fluid impermeable barrier 902 of the cup portion 952 and a penis inserted into the chamber 904. The fluid collection device 900 may include a fluid permeable support 120. The fluid permeable support 120 may be positioned between the cup portion 952 and a penis inserted into the chamber 904, such as between the fluid permeable membrane 118 and the fluid impermeable barrier 902. The sidewalls or the end of the chamber 904 may be covered with one or both the fluid permeable membrane 118 or the fluid permeable support 120.
In some examples, a vacuum source (e.g., vacuum source 16 of
In an example, portions of the chamber 904 may be substantially empty due to the varying sizes and rigidity of the male penis. However, in some examples, the outermost regions of the chamber 904 (e.g., periphery of the interior regions of the cup portion 952) can include a porous material (e.g., one or more of the fluid permeable membrane 118 and fluid permeable support 120) positioned (e.g., at the end of the cavity) and configured to blunt a stream of urine from the male urethra, thereby limiting splashing and/or to direct the fluid(s) to a selected region of the chamber 904. Since the chamber 904 is substantially empty (e.g., substantially all of the chamber 904 forms a reservoir), the fluids are likely to pool at a gravimetrically low point of the chamber 904. The gravimetrically low point of the chamber 904 can be at an intersection of the skin of an individual and the fluid collection device 900, a corner formed in the cup portion 952, or another suitable location depending on the orientation of the wearer. The inlet 110 of the conduit 108 can be positioned to be adjacent or proximate to the gravimetrically low point of the chamber 904, such as adjacent to the annular base 954. For example, the inlet 110 may be co-extensive with or offset from the opening 956. In examples, the inlet may be positioned adjacent to the terminal end of the cup portion 952 (e.g., substantially opposite the opening).
During operation, a male using the fluid collection device 900 can discharge fluid(s) (e.g., urine) into the chamber 904. The fluid(s) can pool or otherwise be collected in the chamber 904. At least some of the fluid(s) can enter the interior of the conduit 108 via the inlet 110. The fluid may be drawn out of the fluid collection device 900 via the vacuum/suction provided by the vacuum source. In some examples, during operation, the passageway 962 may substantially maintain the pressure in the chamber 904 at atmospheric pressure even though fluid is introduced into and subsequently removed from the chamber 904.
Acts 1010, 1020, 1030 of the method 1000 are for illustrative purposes. For example, the act 1010, 1020, 1030 of the method 1000 can be performed in different orders, split into multiple acts, modified, supplemented, or combined. In an example, one or more of the acts 1010, 1020, 1030 of the method 1000 can be omitted from the method 1000. Any of the acts 1010, 1020, or 1030 can include using any of the fluid collection devices or systems disclosed herein.
Act 1010 recites “positioning an opening of a fluid collection device adjacent to a female urethra or around a male urethra of a user, the opening defined by a fluid impermeable barrier of the fluid collection device.” In some examples, act 1010 can include positioning the opening of a female fluid collection device such that the fluid permeable membrane of the female fluid collection device abuts or is positioned proximate to the female urethra. For example, positioning an opening of a fluid collection device adjacent to a female urethra of a user may include positioning opening of the fluid collection member of the fluid collection device on, adjacent to, between the labia. In examples the female fluid collection device may be similar or identical to the fluid collection device 100, 400, 500, 700, or 800 (
In some examples, act 1010 can include positioning the opening of a male fluid collection device around a urethra of a male user such that the urethra of the user is positioned within the fluid collection device. For example, positioning an opening of a fluid collection device around a male urethra of a user may include positioning the penis of a user in the cup portion of the male fluid collection device. In examples the male fluid collection device may be similar or identical to the fluid collection device 900 (
Act 1020 recites, “securing the fluid collection device to the user.” Securing the fluid collection device to the user may include affixing one or more flanges of the fluid collection device to the user or clothing of the user. In examples, securing the fluid collection device to the user can include adhering the adhesion member of the at least one flange of the fluid collection device to the user. In examples, securing the fluid collection device to the user can include adhering the adhesion member(s) of the at least one flange (e.g., flanges) of the fluid collection device to one or more of the lower abdomen, inner thigh(s), testicles, pubic region, hip region, or perineum of the user (or on clothing over any of the aforementioned regions). For example, securing the fluid collection device to the user can include adhering the adhesion member(s) of the at least one flange of the fluid collection device to the inner thigh(s) of a female user. Securing the fluid collection device to the user can include adhering the adhesion member of the at least one flange of the fluid collection device to the garment (e.g., the underwear) of the user. For example, adhering the adhesion member of the at least one flange of the fluid collection device to the garment may include adhering one or more flanges on or around the crotch (e.g., gusset) of underwear of the user. Securing the fluid collection device to the user may include securing the fluid collection device to the user to maintain the opening adjacent to, on, or over the urethra of the user, even when the user moves.
Act 1030 recites “receiving fluid from the female urethra or male urethra into a chamber of the fluid collection device, the chamber of the fluid collection device at least partially defined by the fluid impermeable barrier.” In examples, act 1030 can include retaining the fluid within the chamber, such as in a gravimetrically low point therein. In some examples, act 1030 can include wicking the fluid away from the opening using wicking material (e.g., fluid permeable membrane and a fluid permeable support). In some examples, act 1030 can include receiving the fluid into the chamber of the fluid collection device. In either example, act 1030 can include flowing the fluid towards a portion of the chamber that is in fluid communication with an inlet of a conduit in fluid communication with a vacuum source. For instance, act 1030 can include flowing the fluid to a substantially unoccupied portion of the chamber (e.g., a reservoir), to a gravimetrically low point of the chamber, etc. The fluid can include one or more fluids, such as urine, liquid blood, sweat, etc. In some examples, receiving fluid from the female urethra into a chamber of the fluid collection device, the chamber of the fluid collection device at least partially defined by the fluid impermeable barrier may include wicking the fluid into the chamber via the fluid permeable membrane and fluid permeable support of the fluid collection device. For example, wicking the fluid into the chamber via the fluid permeable membrane and fluid permeable support may include wicking urine into the reservoir in the fluid collection device.
The method 1000 may include removing at least some of the fluid from the fluid collection device. For example, removing at least some of the fluid from the fluid collection device may include removing the fluid from within the chamber of the fluid collection device. Such removal may include applying suction with a vacuum source effective to suction the fluid from the chamber via a conduit disposed therein (which conduit may be in fluid communication with the vacuum source). In examples, removing fluids from the fluid collection device by applying suction with a vacuum source effective to suction (e.g., vacuum) the fluid from the chamber via a conduit disposed therein include using any of the vacuum sources disclosed herein, such as a portable vacuum source. In an example, applying suction can include activating the vacuum source (e.g., portable suction device) in fluid communication with the inlet of the conduit in the fluid collection device. In examples, activating the vacuum source in fluid communication with the inlet of the conduit in the fluid collection device can include supplying power to the vacuum source by one or more of flipping an on/off switch, pressing a button, opening a valve, connecting the fluid collection device into a vacuum line, plugging a portable vacuum source into a power outlet, putting batteries into the portable vacuum source, etc. In examples, the vacuum source may include a hand operated vacuum pump and applying suction with a vacuum source may include manually operating the hand operated vacuum pump effective to suction the fluid from the chamber via the conduit disposed therein that is in fluid communication with the (portable) vacuum source. In examples, the vacuum source may include a plumbed vacuum line and applying suction with a vacuum source may include manually connecting to the plumbed vacuum line to the fluid collection device (e.g., the conduit) or opening a valve therebetween effective to suction the fluid from the chamber via the conduit disposed therein.
In examples, applying suction with a vacuum source effective to suction the fluid from the chamber via a conduit disposed therein and in fluid communication with the vacuum source can be effective to remove at least some fluid (e.g., urine) from the chamber (e.g., interior region) of the fluid collection device. In examples, applying suction with a vacuum source effective to suction the fluid from the chamber via a conduit disposed therein and in fluid communication with the vacuum source can be effective to transfer at least some of the fluid from the chamber of the fluid collection device to a fluid storage container (e.g., a bottle or bag). In some examples, applying suction with a vacuum source effective to suction the fluid(s) from the chamber may include removing fluid from one or more of a reservoir, fluid permeable support, or fluid permeable membrane of the fluid collection device.
In examples, the vacuum source (e.g., suction device) may disposed on or within the fluid collection device and applying suction with the vacuum source may include activating the vacuum source. In examples, the vacuum source may be spaced from the fluid collection device and applying suction with the vacuum source may include activating the vacuum source, such as a portable vacuum source.
In examples, applying suction with a vacuum source effective to suction the fluid from the chamber via a conduit disposed therein and in fluid communication with the vacuum source may include detecting moisture in the chamber (e.g., via one or more moisture sensors) and responsive thereto, activating the vacuum source to provide suction in the chamber. The control of the vacuum source responsive to the signals indicating that moisture or a level thereof is present in the chamber can be automatic, such as via a controller, or may merely provide an indication that a level of moisture is present that may necessitate removal of fluid from the chamber of the fluid collection device. In the latter case, a user may receive the indication and activate the vacuum source such as a pump.
In an example, the method 1000 can include collecting the fluid that is removed from the fluid collection device, such as into a fluid storage container that is spaced from the fluid collection device and in fluid communication with the conduit. The fluid storage container can include any of the fluid storage containers disclosed herein.
While various aspects and embodiments have been disclosed herein, other aspects and embodiments are contemplated. The various aspects and embodiment disclosed herein are for purposes of illustration and are not intended to be limiting.
This application is U.S. Nationalization of PCT International Application No. PCT/US2019/029610 filed on 29 Apr. 2019, which claims priority to U.S. Provisional Application No. 62/665,321 filed on 1 May 2018, the disclosure of each of which is incorporated herein in its entirety by this reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2019/029610 | 4/29/2019 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2019/212951 | 11/7/2019 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1032841 | Koenig | Jul 1912 | A |
1178644 | Johnson | Apr 1916 | A |
1742080 | Jones | Dec 1929 | A |
1979899 | Obrien et al. | Nov 1934 | A |
2262772 | Peder | Nov 1941 | A |
2326881 | Packer | Aug 1943 | A |
2379346 | Farrell | Jun 1945 | A |
2613670 | Edward | Oct 1952 | A |
2616426 | Adele | Nov 1952 | A |
2644234 | Earl | Jul 1953 | A |
2859786 | Tupper | Nov 1958 | A |
2944551 | Carl | Jul 1960 | A |
2968046 | Duke | Jan 1961 | A |
2971512 | Reinhardt | Feb 1961 | A |
3032038 | Swinn | May 1962 | A |
3077883 | Hill | Feb 1963 | A |
3087938 | Hans et al. | Apr 1963 | A |
3194238 | Breece | Jul 1965 | A |
3198994 | Hildebrandt et al. | Aug 1965 | A |
3221742 | Egon | Dec 1965 | A |
3312981 | Mcguire et al. | Apr 1967 | A |
3349768 | Keane | Oct 1967 | A |
3362590 | Gene | Jan 1968 | A |
3366116 | Huck | Jan 1968 | A |
3398848 | Donovan | Aug 1968 | A |
3400717 | Bruce et al. | Sep 1968 | A |
3406688 | Bruce | Oct 1968 | A |
3424163 | Gunnar | Jan 1969 | A |
3425471 | Yates | Feb 1969 | A |
3511241 | Lee | May 1970 | A |
3512185 | Ellis | May 1970 | A |
3520300 | Flower | Jul 1970 | A |
3528423 | Lee | Sep 1970 | A |
3613123 | Langstrom | Oct 1971 | A |
3648700 | Warner | Mar 1972 | A |
3651810 | Ormerod | Mar 1972 | A |
3661155 | Lindan | May 1972 | A |
3699815 | Holbrook | Oct 1972 | A |
3726277 | Hirschman | Apr 1973 | A |
3742952 | Magers et al. | Jul 1973 | A |
3757355 | Allen et al. | Sep 1973 | A |
3788324 | Lim | Jan 1974 | A |
3843016 | Bornhorst et al. | Oct 1974 | A |
3863638 | Rogers et al. | Feb 1975 | A |
3863798 | Kurihara et al. | Feb 1975 | A |
3864759 | Horiuchi | Feb 1975 | A |
3881486 | Fenton | May 1975 | A |
3915189 | Holbrook et al. | Oct 1975 | A |
3998228 | Poidomani | Dec 1976 | A |
3999550 | Martin | Dec 1976 | A |
4015604 | Csillag | Apr 1977 | A |
4020843 | Kanall | May 1977 | A |
4022213 | Stein | May 1977 | A |
4027776 | Douglas | Jun 1977 | A |
4116197 | Bermingham | Sep 1978 | A |
4180178 | Turner | Dec 1979 | A |
4187953 | Turner | Feb 1980 | A |
4194508 | Anderson | Mar 1980 | A |
4200102 | Duhamel | Apr 1980 | A |
4202058 | Anderson | May 1980 | A |
4233025 | Larson et al. | Nov 1980 | A |
4233978 | Hickey | Nov 1980 | A |
4246901 | Frosch et al. | Jan 1981 | A |
4257418 | Hessner | Mar 1981 | A |
4270539 | Frosch et al. | Jun 1981 | A |
4281655 | Terauchi | Aug 1981 | A |
4292916 | Bradley et al. | Oct 1981 | A |
4352356 | Tong | Oct 1982 | A |
4360933 | Kimura et al. | Nov 1982 | A |
4365363 | Windauer | Dec 1982 | A |
4387726 | Denard | Jun 1983 | A |
4425130 | Desmarais | Jan 1984 | A |
4446986 | Bowen et al. | May 1984 | A |
4453938 | Brendling | Jun 1984 | A |
4457314 | Knowles | Jul 1984 | A |
4476879 | Jackson | Oct 1984 | A |
4526688 | Schmidt, Jr. et al. | Jul 1985 | A |
4528703 | Kraus | Jul 1985 | A |
D280438 | Wendt | Sep 1985 | S |
4551141 | Mcneil | Nov 1985 | A |
4553968 | Komis | Nov 1985 | A |
4581026 | Schneider | Apr 1986 | A |
4610675 | Triunfol | Sep 1986 | A |
4620333 | Ritter | Nov 1986 | A |
4626250 | Schneider | Dec 1986 | A |
4627846 | Ternstroem | Dec 1986 | A |
4631061 | Martin | Dec 1986 | A |
4650477 | Johnson | Mar 1987 | A |
4656675 | Fajnsztajn | Apr 1987 | A |
4681570 | Dalton | Jul 1987 | A |
4692160 | Nussbaumer | Sep 1987 | A |
4707864 | Ikematsu et al. | Nov 1987 | A |
4713066 | Komis | Dec 1987 | A |
4747166 | Kuntz | May 1988 | A |
4752944 | Conrads et al. | Jun 1988 | A |
4769215 | Ehrenkranz | Sep 1988 | A |
4772280 | Rooyakkers | Sep 1988 | A |
4790830 | Hamacher | Dec 1988 | A |
4790835 | Elias | Dec 1988 | A |
4791686 | Taniguchi et al. | Dec 1988 | A |
4795449 | Schneider | Jan 1989 | A |
4798603 | Meyer et al. | Jan 1989 | A |
4799928 | Crowley | Jan 1989 | A |
4804377 | Hanifl et al. | Feb 1989 | A |
4812053 | Bhattacharjee | Mar 1989 | A |
4820297 | Kaufman et al. | Apr 1989 | A |
4846818 | Keldahl et al. | Jul 1989 | A |
4846909 | Klug et al. | Jul 1989 | A |
4865595 | Heyden | Sep 1989 | A |
4880417 | Yabrov et al. | Nov 1989 | A |
4882794 | Stewart, III | Nov 1989 | A |
4883465 | Brennan | Nov 1989 | A |
4886508 | Washington | Dec 1989 | A |
4886509 | Mattsson | Dec 1989 | A |
4889532 | Metz et al. | Dec 1989 | A |
4889533 | Beecher | Dec 1989 | A |
4903254 | Haas | Feb 1990 | A |
4905692 | More | Mar 1990 | A |
4936838 | Cross et al. | Jun 1990 | A |
4955922 | Terauchi | Sep 1990 | A |
4957487 | Gerow | Sep 1990 | A |
4965460 | Tanaka et al. | Oct 1990 | A |
4987849 | Sherman | Jan 1991 | A |
5002541 | Conkling et al. | Mar 1991 | A |
5004463 | Nigay | Apr 1991 | A |
5031248 | Kemper | Jul 1991 | A |
5045077 | Blake | Sep 1991 | A |
5045283 | Patel | Sep 1991 | A |
5049144 | Payton | Sep 1991 | A |
5053339 | Patel | Oct 1991 | A |
5058088 | Haas et al. | Oct 1991 | A |
5071347 | Mcguire | Dec 1991 | A |
5078707 | Peter | Jan 1992 | A |
5084037 | Barnett | Jan 1992 | A |
5100396 | Zamierowski | Mar 1992 | A |
5147301 | Ruvio | Sep 1992 | A |
5195997 | Carns | Mar 1993 | A |
5203699 | Mcguire | Apr 1993 | A |
5244458 | Takasu | Sep 1993 | A |
5246454 | Peterson | Sep 1993 | A |
5267988 | Farkas | Dec 1993 | A |
5275307 | Freese | Jan 1994 | A |
5294983 | Ersoz et al. | Mar 1994 | A |
5295983 | Kubo | Mar 1994 | A |
5300052 | Kubo | Apr 1994 | A |
5312383 | Kubalak | May 1994 | A |
5318550 | Cermak et al. | Jun 1994 | A |
5340840 | Park et al. | Aug 1994 | A |
5382244 | Telang | Jan 1995 | A |
5423784 | Metz | Jun 1995 | A |
5466229 | Elson et al. | Nov 1995 | A |
5478334 | Bernstein | Dec 1995 | A |
5499977 | Marx | Mar 1996 | A |
5543042 | Filan et al. | Aug 1996 | A |
D373928 | Green | Sep 1996 | S |
5605161 | Cross | Feb 1997 | A |
5618277 | Goulter | Apr 1997 | A |
5628735 | Skow | May 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5637104 | Ball et al. | Jun 1997 | A |
5674212 | Osborn, III et al. | Oct 1997 | A |
5678564 | Lawrence et al. | Oct 1997 | A |
5678654 | Uzawa | Oct 1997 | A |
5687429 | Rahlff | Nov 1997 | A |
5695485 | Duperret et al. | Dec 1997 | A |
5752944 | Dann et al. | May 1998 | A |
5772644 | Bark et al. | Jun 1998 | A |
5792132 | Garcia | Aug 1998 | A |
5827243 | Palestrant | Oct 1998 | A |
5827247 | Kay | Oct 1998 | A |
5827250 | Fujioka et al. | Oct 1998 | A |
5827257 | Fujioka et al. | Oct 1998 | A |
D401699 | Herchenbach et al. | Nov 1998 | S |
5865378 | Hollinshead et al. | Feb 1999 | A |
5887291 | Bellizzi | Mar 1999 | A |
5894608 | Birbara | Apr 1999 | A |
D409303 | Oepping | May 1999 | S |
5911222 | Lawrence et al. | Jun 1999 | A |
5957904 | Holland | Sep 1999 | A |
5968026 | Osborn, III | Oct 1999 | A |
5972505 | Phillips et al. | Oct 1999 | A |
6050983 | Moore et al. | Apr 2000 | A |
6059762 | Boyer et al. | May 2000 | A |
6063064 | Tuckey et al. | May 2000 | A |
6098625 | Winkler | Aug 2000 | A |
6105174 | Karlsten et al. | Aug 2000 | A |
6113582 | Dwork | Sep 2000 | A |
6117163 | Bierman | Sep 2000 | A |
6123398 | Arai | Sep 2000 | A |
6129718 | Wada et al. | Oct 2000 | A |
6131964 | Sareshwala | Oct 2000 | A |
6152902 | Christian et al. | Nov 2000 | A |
6164569 | Hollinshead et al. | Dec 2000 | A |
6177606 | Etheredge et al. | Jan 2001 | B1 |
6209142 | Mattsson et al. | Apr 2001 | B1 |
6248096 | Dwork et al. | Jun 2001 | B1 |
6263887 | Dunn | Jul 2001 | B1 |
6311339 | Kraus | Nov 2001 | B1 |
6336919 | Davis et al. | Jan 2002 | B1 |
6338729 | Wada et al. | Jan 2002 | B1 |
6352525 | Wakabayashi | Mar 2002 | B1 |
6394988 | Hashimoto | May 2002 | B1 |
6398742 | Kim | Jun 2002 | B1 |
6406463 | Brown | Jun 2002 | B1 |
6409712 | Dutari et al. | Jun 2002 | B1 |
6416500 | Wada et al. | Jul 2002 | B1 |
6428521 | Droll | Aug 2002 | B1 |
6475198 | Lipman et al. | Nov 2002 | B1 |
6479726 | Cole et al. | Nov 2002 | B1 |
6491673 | Palumbo et al. | Dec 2002 | B1 |
6508794 | Palumbo et al. | Jan 2003 | B1 |
6540729 | Wada et al. | Apr 2003 | B1 |
6547771 | Robertson et al. | Apr 2003 | B2 |
6569133 | Cheng et al. | May 2003 | B2 |
D476518 | Doppelt | Jul 2003 | S |
6592560 | Snyder et al. | Jul 2003 | B2 |
6618868 | Minnick | Sep 2003 | B2 |
6620142 | Flueckiger | Sep 2003 | B1 |
6629651 | Male et al. | Oct 2003 | B1 |
6635038 | Scovel | Oct 2003 | B2 |
6652495 | Walker | Nov 2003 | B1 |
6685684 | Falconer | Feb 2004 | B1 |
6702793 | Sweetser et al. | Mar 2004 | B1 |
6706027 | Harvie | Mar 2004 | B2 |
6732384 | Scott | May 2004 | B2 |
6736977 | Hall et al. | May 2004 | B1 |
6740066 | Wolff | May 2004 | B2 |
6764477 | Chen et al. | Jul 2004 | B1 |
6783519 | Samuelsson | Aug 2004 | B2 |
6796974 | Palumbo et al. | Sep 2004 | B2 |
6814547 | Childers et al. | Nov 2004 | B2 |
6849065 | Schmidt et al. | Feb 2005 | B2 |
6857137 | Otto | Feb 2005 | B2 |
6885690 | Aggerstam et al. | Apr 2005 | B2 |
6888044 | Fell et al. | May 2005 | B2 |
6893425 | Dunn et al. | May 2005 | B2 |
6912737 | Ernest et al. | Jul 2005 | B2 |
6918899 | Harvie | Jul 2005 | B2 |
6979324 | Bybordi et al. | Dec 2005 | B2 |
7018366 | Easter | Mar 2006 | B2 |
7066411 | Male et al. | Jun 2006 | B2 |
7122023 | Hinoki | Oct 2006 | B1 |
7125399 | Miskie | Oct 2006 | B2 |
7131964 | Harvie | Nov 2006 | B2 |
7135012 | Harvie | Nov 2006 | B2 |
7141043 | Harvie | Nov 2006 | B2 |
D533972 | La | Dec 2006 | S |
7160273 | Greter et al. | Jan 2007 | B2 |
7171699 | Ernest et al. | Feb 2007 | B2 |
7171871 | Kozak | Feb 2007 | B2 |
7179951 | Krishnaswamy-mirle et al. | Feb 2007 | B2 |
7181781 | Trabold | Feb 2007 | B1 |
7186245 | Cheng et al. | Mar 2007 | B1 |
7192424 | Cooper | Mar 2007 | B2 |
7220250 | Suzuki | May 2007 | B2 |
D562975 | Otto | Feb 2008 | S |
7335189 | Harvie | Feb 2008 | B2 |
7358282 | Krueger et al. | Apr 2008 | B2 |
7390320 | Machida | Jun 2008 | B2 |
7438706 | Koizumi et al. | Oct 2008 | B2 |
7488310 | Yang | Feb 2009 | B2 |
7491194 | Oliwa | Feb 2009 | B1 |
D591106 | Dominique et al. | Apr 2009 | S |
7513381 | Heng et al. | Apr 2009 | B2 |
7520872 | Biggie et al. | Apr 2009 | B2 |
D593801 | Wilson et al. | Jun 2009 | S |
7540364 | Sanderson | Jun 2009 | B2 |
7585293 | Vermaak | Sep 2009 | B2 |
7588560 | Dunlop | Sep 2009 | B1 |
7665359 | Barber | Feb 2010 | B2 |
7682347 | Parks et al. | Mar 2010 | B2 |
7687004 | Allen | Mar 2010 | B2 |
7695459 | Gilbert et al. | Apr 2010 | B2 |
7695460 | Wada et al. | Apr 2010 | B2 |
7699818 | Gilbert | Apr 2010 | B2 |
7699831 | Bengtson | Apr 2010 | B2 |
7722584 | Tanaka et al. | May 2010 | B2 |
7727206 | Gorres | Jun 2010 | B2 |
7740620 | Gilbert et al. | Jun 2010 | B2 |
7749205 | Tazoe | Jul 2010 | B2 |
7755497 | Wada | Jul 2010 | B2 |
7766887 | Burns, Jr. et al. | Aug 2010 | B2 |
D625407 | Koizumi et al. | Oct 2010 | S |
7806879 | Brooks et al. | Oct 2010 | B2 |
7811272 | Lindsay et al. | Oct 2010 | B2 |
7815067 | Matsumoto et al. | Oct 2010 | B2 |
7833169 | Hannon | Nov 2010 | B2 |
7857806 | Karpowicz et al. | Dec 2010 | B2 |
7866942 | Harvie | Jan 2011 | B2 |
7871385 | Levinson et al. | Jan 2011 | B2 |
7875010 | Frazier et al. | Jan 2011 | B2 |
7901389 | Mombrinie | Mar 2011 | B2 |
7927320 | Goldwasser et al. | Apr 2011 | B2 |
7927321 | Marland | Apr 2011 | B2 |
7931634 | Swiecicki et al. | Apr 2011 | B2 |
7939706 | Okabe et al. | May 2011 | B2 |
7946443 | Stull et al. | May 2011 | B2 |
7947025 | Buglino et al. | May 2011 | B2 |
7963419 | Burney et al. | Jun 2011 | B2 |
7976519 | Bubb et al. | Jul 2011 | B2 |
7993318 | Olsson et al. | Aug 2011 | B2 |
8015627 | Baker et al. | Sep 2011 | B2 |
8028460 | Williams | Oct 2011 | B2 |
8047398 | Dimartino et al. | Nov 2011 | B2 |
8083094 | Caulfield et al. | Dec 2011 | B2 |
8128608 | Thevenin | Mar 2012 | B2 |
8181651 | Pinel | May 2012 | B2 |
8181819 | Burney et al. | May 2012 | B2 |
8211063 | Bierman | Jul 2012 | B2 |
8221369 | Parks et al. | Jul 2012 | B2 |
8241262 | Mahnensmith | Aug 2012 | B2 |
8277426 | Wilcox et al. | Oct 2012 | B2 |
8287508 | Sanchez | Oct 2012 | B1 |
8303554 | Tsai et al. | Nov 2012 | B2 |
8322565 | Caulfield et al. | Dec 2012 | B2 |
8337477 | Parks et al. | Dec 2012 | B2 |
D674241 | Bickert et al. | Jan 2013 | S |
8343122 | Gorres | Jan 2013 | B2 |
8353074 | Krebs | Jan 2013 | B2 |
8353886 | Bester et al. | Jan 2013 | B2 |
D676241 | Merrill | Feb 2013 | S |
8388588 | Wada et al. | Mar 2013 | B2 |
D679807 | Burgess et al. | Apr 2013 | S |
8425482 | Khoubnazar | Apr 2013 | B2 |
8449510 | Martini et al. | May 2013 | B2 |
D684260 | Lund et al. | Jun 2013 | S |
8470230 | Caulfield et al. | Jun 2013 | B2 |
8479941 | Matsumoto et al. | Jul 2013 | B2 |
8479949 | Henkel | Jul 2013 | B2 |
8512301 | Ma | Aug 2013 | B2 |
8529530 | Koch et al. | Sep 2013 | B2 |
8535284 | Joder et al. | Sep 2013 | B2 |
8546639 | Wada | Oct 2013 | B2 |
8551075 | Bengtson | Oct 2013 | B2 |
8568376 | Delattre et al. | Oct 2013 | B2 |
D694404 | Burgess et al. | Nov 2013 | S |
8585683 | Bengtson | Nov 2013 | B2 |
8652112 | Johannison et al. | Feb 2014 | B2 |
D702973 | Norland et al. | Apr 2014 | S |
8703032 | Menon et al. | Apr 2014 | B2 |
D704330 | Cicatelli | May 2014 | S |
D704510 | Mason et al. | May 2014 | S |
D705423 | Walsh Cutler | May 2014 | S |
D705926 | Burgess et al. | May 2014 | S |
8714394 | Wulf | May 2014 | B2 |
8715267 | Bengtson et al. | May 2014 | B2 |
8757425 | Copeland | Jun 2014 | B2 |
8777032 | Biesecker et al. | Jul 2014 | B2 |
8808260 | Koch et al. | Aug 2014 | B2 |
8864730 | Conway et al. | Oct 2014 | B2 |
8881923 | Higginson | Nov 2014 | B2 |
8882731 | Suzuki | Nov 2014 | B2 |
8936585 | Carson et al. | Jan 2015 | B2 |
D729581 | Boroski | May 2015 | S |
9028460 | Medeiros | May 2015 | B2 |
9056698 | Noer | Jun 2015 | B2 |
9078792 | Ruiz | Jul 2015 | B2 |
9173602 | Gilbert | Nov 2015 | B2 |
9173799 | Tanimoto | Nov 2015 | B2 |
9187220 | Biesecker et al. | Nov 2015 | B2 |
9199772 | Krippendorf | Dec 2015 | B2 |
9233020 | Matsumiya | Jan 2016 | B2 |
9248058 | Conway et al. | Feb 2016 | B2 |
9308118 | Dupree et al. | Apr 2016 | B1 |
9309029 | Incorvia et al. | Apr 2016 | B2 |
9333281 | Giezendanner et al. | May 2016 | B2 |
9382047 | Schmidtner et al. | Jul 2016 | B2 |
9456937 | Ellis | Oct 2016 | B2 |
9480595 | Baham et al. | Nov 2016 | B2 |
9517865 | Albers et al. | Dec 2016 | B2 |
D777941 | Piramoon | Jan 2017 | S |
9533806 | Ding et al. | Jan 2017 | B2 |
9550611 | Hodge | Jan 2017 | B2 |
9555930 | Campbell et al. | Jan 2017 | B2 |
9623159 | Locke | Apr 2017 | B2 |
D789522 | Burgess et al. | Jun 2017 | S |
9687849 | Bruno et al. | Jun 2017 | B2 |
9694949 | Hendricks et al. | Jul 2017 | B2 |
9713547 | Lee et al. | Jul 2017 | B2 |
9788992 | Harvie | Oct 2017 | B2 |
D804907 | Sandoval | Dec 2017 | S |
9868564 | Mcgirr et al. | Jan 2018 | B2 |
D814239 | Arora | Apr 2018 | S |
D817484 | Lafond | May 2018 | S |
10037640 | Gordon | Jul 2018 | B2 |
10058470 | Phillips | Aug 2018 | B2 |
10098990 | Koch et al. | Oct 2018 | B2 |
D835264 | Mozzicato et al. | Dec 2018 | S |
D835779 | Mozzicato et al. | Dec 2018 | S |
D840533 | Mozzicato et al. | Feb 2019 | S |
D840534 | Mozzicato et al. | Feb 2019 | S |
10225376 | Perez Martinez | Mar 2019 | B2 |
10226376 | Sanchez | Mar 2019 | B2 |
D848612 | Mozzicato et al. | May 2019 | S |
10307305 | Hodges | Jun 2019 | B1 |
10335121 | Desai | Jul 2019 | B2 |
D856512 | Cowart et al. | Aug 2019 | S |
10376406 | Newton | Aug 2019 | B2 |
10376407 | Newton | Aug 2019 | B2 |
10390989 | Sanchez | Aug 2019 | B2 |
D858144 | Fu | Sep 2019 | S |
10406039 | Villarreal | Sep 2019 | B2 |
10407222 | Allen | Sep 2019 | B2 |
10478356 | Griffin | Nov 2019 | B2 |
10538366 | Pentelovitch et al. | Jan 2020 | B2 |
10569938 | Zhao et al. | Feb 2020 | B2 |
10577156 | Dagnelie et al. | Mar 2020 | B2 |
10618721 | Vazin | Apr 2020 | B2 |
D884390 | Wang | May 2020 | S |
10669079 | Freedman et al. | Jun 2020 | B2 |
D892315 | Airy | Aug 2020 | S |
10730672 | Bertram et al. | Aug 2020 | B2 |
10737848 | Philip et al. | Aug 2020 | B2 |
10765854 | Law et al. | Sep 2020 | B2 |
10766670 | Kittmann | Sep 2020 | B2 |
10799386 | Harrison | Oct 2020 | B1 |
D901214 | Hu | Nov 2020 | S |
10857025 | Davis | Dec 2020 | B2 |
10865017 | Cowart et al. | Dec 2020 | B1 |
10889412 | West et al. | Jan 2021 | B2 |
10913581 | Stahlecker | Feb 2021 | B2 |
D912244 | Rehm et al. | Mar 2021 | S |
10952889 | Newton | Mar 2021 | B2 |
10973678 | Newton | Apr 2021 | B2 |
10974874 | Ragias et al. | Apr 2021 | B2 |
11000401 | Ecklund et al. | May 2021 | B2 |
D923365 | Wang | Jun 2021 | S |
11026829 | Harvie | Jun 2021 | B2 |
11027900 | Liu | Jun 2021 | B2 |
11045346 | Argent et al. | Jun 2021 | B2 |
D928946 | Sanchez | Aug 2021 | S |
11179506 | Barr et al. | Nov 2021 | B2 |
11226376 | Yamauchi et al. | Jan 2022 | B2 |
11376152 | Sanchez | Jul 2022 | B2 |
11382786 | Sanchez | Jul 2022 | B2 |
11382788 | Hjorth et al. | Jul 2022 | B2 |
11426303 | Davis | Aug 2022 | B2 |
11529252 | Glithero | Dec 2022 | B2 |
20010037097 | Cheng et al. | Nov 2001 | A1 |
20010054426 | Knudson et al. | Dec 2001 | A1 |
20020019614 | Woon | Feb 2002 | A1 |
20020026161 | Grundke | Feb 2002 | A1 |
20020087131 | Wolff et al. | Jul 2002 | A1 |
20020091364 | Prabhakar | Jul 2002 | A1 |
20020189992 | Schmidt et al. | Dec 2002 | A1 |
20020193760 | Thompson | Dec 2002 | A1 |
20030004436 | Schmidt et al. | Jan 2003 | A1 |
20030120178 | Heki | Jun 2003 | A1 |
20030157859 | Ishikawa | Aug 2003 | A1 |
20030181880 | Schwartz | Sep 2003 | A1 |
20030195484 | Harvie | Oct 2003 | A1 |
20030233079 | Parks et al. | Dec 2003 | A1 |
20040006321 | Cheng et al. | Jan 2004 | A1 |
20040056122 | Male et al. | Mar 2004 | A1 |
20040084465 | Luburic | May 2004 | A1 |
20040127872 | Petryk et al. | Jul 2004 | A1 |
20040128749 | Scott | Jul 2004 | A1 |
20040143229 | Easter | Jul 2004 | A1 |
20040147894 | Mizutani et al. | Jul 2004 | A1 |
20040158221 | Mizutani et al. | Aug 2004 | A1 |
20040176731 | Cheng et al. | Sep 2004 | A1 |
20040191919 | Unger et al. | Sep 2004 | A1 |
20040207530 | Nielsen | Oct 2004 | A1 |
20040236292 | Tazoe | Nov 2004 | A1 |
20040254547 | Okabe | Dec 2004 | A1 |
20050010182 | Parks et al. | Jan 2005 | A1 |
20050033248 | Machida | Feb 2005 | A1 |
20050065471 | Kuntz | Mar 2005 | A1 |
20050070861 | Okabe | Mar 2005 | A1 |
20050070862 | Tazoe | Mar 2005 | A1 |
20050082300 | Modrell et al. | Apr 2005 | A1 |
20050097662 | Leimkuhler et al. | May 2005 | A1 |
20050101924 | Elson et al. | May 2005 | A1 |
20050137557 | Swiecicki et al. | Jun 2005 | A1 |
20050154360 | Harvie | Jul 2005 | A1 |
20050177070 | Levinson et al. | Aug 2005 | A1 |
20050197639 | Mombrinie | Sep 2005 | A1 |
20050273920 | Marinas | Dec 2005 | A1 |
20050277904 | Chase et al. | Dec 2005 | A1 |
20050279359 | LeBlanc et al. | Dec 2005 | A1 |
20060004332 | Marx | Jan 2006 | A1 |
20060015080 | Mahnensmith | Jan 2006 | A1 |
20060015081 | Suzuki | Jan 2006 | A1 |
20060016778 | Park | Jan 2006 | A1 |
20060079854 | Kay et al. | Apr 2006 | A1 |
20060111648 | Vermaak | May 2006 | A1 |
20060155214 | Wightman | Jul 2006 | A1 |
20060200102 | Cooper | Sep 2006 | A1 |
20060229576 | Conway et al. | Oct 2006 | A1 |
20060231648 | Male et al. | Oct 2006 | A1 |
20060235266 | Nan | Oct 2006 | A1 |
20060235359 | Marland | Oct 2006 | A1 |
20060277670 | Baker et al. | Dec 2006 | A1 |
20070006368 | Key et al. | Jan 2007 | A1 |
20070038194 | Wada | Feb 2007 | A1 |
20070055209 | Patel et al. | Mar 2007 | A1 |
20070073252 | Forgrave | Mar 2007 | A1 |
20070117880 | Elson et al. | May 2007 | A1 |
20070135786 | Schmidt et al. | Jun 2007 | A1 |
20070149935 | Dirico | Jun 2007 | A1 |
20070191804 | Coley | Aug 2007 | A1 |
20070214553 | Carromba | Sep 2007 | A1 |
20070225666 | Otto | Sep 2007 | A1 |
20070225668 | Otto | Sep 2007 | A1 |
20070266486 | Ramirez | Nov 2007 | A1 |
20070282309 | Bengtson et al. | Dec 2007 | A1 |
20080004576 | Tanaka et al. | Jan 2008 | A1 |
20080015526 | Reiner et al. | Jan 2008 | A1 |
20080015527 | House | Jan 2008 | A1 |
20080033386 | Okabe | Feb 2008 | A1 |
20080041869 | Backaert | Feb 2008 | A1 |
20080091153 | Harvie | Apr 2008 | A1 |
20080091158 | Yang | Apr 2008 | A1 |
20080167634 | Kouta et al. | Jul 2008 | A1 |
20080183157 | Walters | Jul 2008 | A1 |
20080215031 | Belfort et al. | Sep 2008 | A1 |
20080234642 | Patterson et al. | Sep 2008 | A1 |
20080281282 | Finger et al. | Nov 2008 | A1 |
20080287894 | Van Den Heuvel | Nov 2008 | A1 |
20090025717 | Pinel | Jan 2009 | A1 |
20090048570 | Jensen | Feb 2009 | A1 |
20090056003 | Ivie et al. | Mar 2009 | A1 |
20090069761 | Vogel | Mar 2009 | A1 |
20090069765 | Wortham | Mar 2009 | A1 |
20090192482 | Dodge, II | Jul 2009 | A1 |
20090234312 | Otoole et al. | Sep 2009 | A1 |
20090251510 | Noro et al. | Oct 2009 | A1 |
20090264840 | Virginio | Oct 2009 | A1 |
20090270822 | Medeiros | Oct 2009 | A1 |
20090281510 | Fisher | Nov 2009 | A1 |
20100004612 | Thevenin | Jan 2010 | A1 |
20100058660 | Williams | Mar 2010 | A1 |
20100121289 | Parks et al. | May 2010 | A1 |
20100185168 | Graauw | Jul 2010 | A1 |
20100198172 | Wada et al. | Aug 2010 | A1 |
20100211032 | Tsai | Aug 2010 | A1 |
20100234820 | Tsai et al. | Sep 2010 | A1 |
20100241104 | Gilbert | Sep 2010 | A1 |
20100263113 | Shelton et al. | Oct 2010 | A1 |
20100310845 | Bond et al. | Dec 2010 | A1 |
20110028922 | Kay et al. | Feb 2011 | A1 |
20110034889 | Smith | Feb 2011 | A1 |
20110036837 | Shang | Feb 2011 | A1 |
20110040267 | Wada | Feb 2011 | A1 |
20110040271 | Rogers | Feb 2011 | A1 |
20110054426 | Stewart et al. | Mar 2011 | A1 |
20110060300 | Weig | Mar 2011 | A1 |
20110077495 | Gilbert | Mar 2011 | A1 |
20110077606 | Wilcox et al. | Mar 2011 | A1 |
20110087337 | Forsell | Apr 2011 | A1 |
20110145993 | Rader et al. | Jun 2011 | A1 |
20110152802 | Dicamillo et al. | Jun 2011 | A1 |
20110164147 | Takahashi et al. | Jul 2011 | A1 |
20110172620 | Khambatta | Jul 2011 | A1 |
20110172625 | Wada | Jul 2011 | A1 |
20110202024 | Cozzens | Aug 2011 | A1 |
20110238023 | Slayton | Sep 2011 | A1 |
20110240648 | Tucker | Oct 2011 | A1 |
20110251572 | Nishtala et al. | Oct 2011 | A1 |
20110265889 | Tanaka et al. | Nov 2011 | A1 |
20110276020 | Mitsui | Nov 2011 | A1 |
20120035577 | Tomes et al. | Feb 2012 | A1 |
20120041400 | Christensen | Feb 2012 | A1 |
20120059328 | Dikeman et al. | Mar 2012 | A1 |
20120066825 | Birbara et al. | Mar 2012 | A1 |
20120103347 | Wheaton | May 2012 | A1 |
20120137420 | Gordon et al. | Jun 2012 | A1 |
20120165768 | Sekiyama et al. | Jun 2012 | A1 |
20120165786 | Chappa et al. | Jun 2012 | A1 |
20120210503 | Anzivino, Sr. | Aug 2012 | A1 |
20120233761 | Huang | Sep 2012 | A1 |
20120245541 | Suzuki | Sep 2012 | A1 |
20120245542 | Suzuki | Sep 2012 | A1 |
20120245547 | Wilcox et al. | Sep 2012 | A1 |
20120253303 | Suzuki | Oct 2012 | A1 |
20120271259 | Ulert | Oct 2012 | A1 |
20120296305 | Barraza Khaled et al. | Nov 2012 | A1 |
20120330256 | Wilcox et al. | Dec 2012 | A1 |
20130006206 | Wada | Jan 2013 | A1 |
20130045651 | Esteves et al. | Feb 2013 | A1 |
20130053804 | Soerensen et al. | Feb 2013 | A1 |
20130096523 | Chang et al. | Apr 2013 | A1 |
20130245496 | Wells et al. | Sep 2013 | A1 |
20130245586 | Jha | Sep 2013 | A1 |
20130292537 | Dirico | Nov 2013 | A1 |
20140031774 | Bengtson | Jan 2014 | A1 |
20140157499 | Suzuki et al. | Jun 2014 | A1 |
20140171889 | Hopman et al. | Jun 2014 | A1 |
20140182051 | Tanimoto | Jul 2014 | A1 |
20140196189 | Lee et al. | Jul 2014 | A1 |
20140303582 | Wright et al. | Oct 2014 | A1 |
20140316381 | Reglin | Oct 2014 | A1 |
20140325746 | Block | Nov 2014 | A1 |
20140348139 | Gomez Martinez | Nov 2014 | A1 |
20140352050 | Yao et al. | Dec 2014 | A1 |
20140371628 | Desai | Dec 2014 | A1 |
20150045757 | Lee et al. | Feb 2015 | A1 |
20150047114 | Ramirez | Feb 2015 | A1 |
20150048089 | Robertson | Feb 2015 | A1 |
20150135423 | Sharpe et al. | May 2015 | A1 |
20150157300 | Ealovega et al. | Jun 2015 | A1 |
20150209194 | Heyman | Jul 2015 | A1 |
20150290425 | Macy et al. | Oct 2015 | A1 |
20150320583 | Harvie | Nov 2015 | A1 |
20150329255 | Rzepecki | Nov 2015 | A1 |
20150359660 | Harvie | Dec 2015 | A1 |
20150366699 | Nelson | Dec 2015 | A1 |
20160029998 | Brister et al. | Feb 2016 | A1 |
20160030228 | Jones | Feb 2016 | A1 |
20160038356 | Yao et al. | Feb 2016 | A1 |
20160058322 | Brister et al. | Mar 2016 | A1 |
20160060001 | Wada et al. | Mar 2016 | A1 |
20160100976 | Conway et al. | Apr 2016 | A1 |
20160106604 | Timm | Apr 2016 | A1 |
20160113809 | Kim | Apr 2016 | A1 |
20160183689 | Miner | Jun 2016 | A1 |
20160256022 | Le | Sep 2016 | A1 |
20160270982 | Raycheck et al. | Sep 2016 | A1 |
20160278662 | Brister et al. | Sep 2016 | A1 |
20160357400 | Penha et al. | Dec 2016 | A1 |
20160366699 | Zhang et al. | Dec 2016 | A1 |
20160367226 | Newton | Dec 2016 | A1 |
20160367411 | Justiz et al. | Dec 2016 | A1 |
20160374848 | Sanchez | Dec 2016 | A1 |
20170007438 | Harvie | Jan 2017 | A1 |
20170014560 | Minskoff et al. | Jan 2017 | A1 |
20170100276 | Joh | Apr 2017 | A1 |
20170128638 | Giezendanner et al. | May 2017 | A1 |
20170143534 | Sanchez | May 2017 | A1 |
20170165405 | Muser et al. | Jun 2017 | A1 |
20170189225 | Voorhees et al. | Jul 2017 | A1 |
20170202692 | Laniado | Jul 2017 | A1 |
20170216081 | Accosta | Aug 2017 | A1 |
20170246026 | Laniado | Aug 2017 | A1 |
20170252014 | Siller Gonzalez et al. | Sep 2017 | A1 |
20170252202 | Sanchez et al. | Sep 2017 | A9 |
20170266031 | Sanchez | Sep 2017 | A1 |
20170266658 | Bruno et al. | Sep 2017 | A1 |
20170281399 | VanMiddendorp | Oct 2017 | A1 |
20170312116 | Laniado | Nov 2017 | A1 |
20170325788 | Ealovega et al. | Nov 2017 | A1 |
20170333244 | Laniado | Nov 2017 | A1 |
20170042748 | Griffin | Dec 2017 | A1 |
20170348139 | Newton | Dec 2017 | A1 |
20170354532 | Holt | Dec 2017 | A1 |
20170367873 | Grannum | Dec 2017 | A1 |
20180002075 | Lee | Jan 2018 | A1 |
20180008451 | Stroebech | Jan 2018 | A1 |
20180008804 | Laniado | Jan 2018 | A1 |
20180028349 | Newton | Feb 2018 | A1 |
20180037384 | Archeny et al. | Feb 2018 | A1 |
20180049910 | Newton | Feb 2018 | A1 |
20180064572 | Wiltshire | Mar 2018 | A1 |
20180104131 | Killian | Apr 2018 | A1 |
20180127187 | Sewell | May 2018 | A1 |
20180193215 | Davies et al. | Jul 2018 | A1 |
20180200101 | Su | Jul 2018 | A1 |
20180228642 | Davis | Aug 2018 | A1 |
20180256384 | Kasirye | Sep 2018 | A1 |
20180271694 | Fernandez et al. | Sep 2018 | A1 |
20180317892 | Catlin | Nov 2018 | A1 |
20190001030 | Braga et al. | Jan 2019 | A1 |
20190021899 | Vlet | Jan 2019 | A1 |
20190038451 | Harvie | Feb 2019 | A1 |
20190046102 | Kushnir et al. | Feb 2019 | A1 |
20190100362 | Meyers et al. | Apr 2019 | A1 |
20190133814 | Tammen et al. | May 2019 | A1 |
20190142624 | Sanchez | May 2019 | A1 |
20190224036 | Sanchez | Jul 2019 | A1 |
20190247222 | Ecklund et al. | Aug 2019 | A1 |
20190247223 | Brun et al. | Aug 2019 | A1 |
20190282391 | Johannes et al. | Sep 2019 | A1 |
20190314189 | Acosta | Oct 2019 | A1 |
20190314190 | Sanchez | Oct 2019 | A1 |
20190344934 | Faerber et al. | Nov 2019 | A1 |
20190365307 | Laing et al. | Dec 2019 | A1 |
20190365561 | Newton et al. | Dec 2019 | A1 |
20200008985 | Nguyen et al. | Jan 2020 | A1 |
20200030595 | Boukidjian et al. | Jan 2020 | A1 |
20200046544 | Godinez | Feb 2020 | A1 |
20200055638 | Lau et al. | Feb 2020 | A1 |
20200070392 | Huber et al. | Mar 2020 | A1 |
20200085610 | Cohn et al. | Mar 2020 | A1 |
20200086090 | Von Weymarn-schärli et al. | Mar 2020 | A1 |
20200129322 | Leuckel | Apr 2020 | A1 |
20200171217 | Braga et al. | Jun 2020 | A9 |
20200229964 | Staali et al. | Jul 2020 | A1 |
20200231343 | Freedman et al. | Jul 2020 | A1 |
20200232841 | Satish et al. | Jul 2020 | A1 |
20200255189 | Liu | Aug 2020 | A1 |
20200261280 | Heyman | Aug 2020 | A1 |
20200276046 | Staali et al. | Sep 2020 | A1 |
20200306075 | Newton et al. | Oct 2020 | A1 |
20200315838 | Eckert | Oct 2020 | A1 |
20200331672 | Bertram et al. | Oct 2020 | A1 |
20200345332 | Duval | Nov 2020 | A1 |
20200353135 | Gregory et al. | Nov 2020 | A1 |
20200367677 | Silsby et al. | Nov 2020 | A1 |
20200369444 | Silsby et al. | Nov 2020 | A1 |
20200375781 | Staali et al. | Dec 2020 | A1 |
20200385179 | Mccourt | Dec 2020 | A1 |
20200390591 | Glithero | Dec 2020 | A1 |
20200390592 | Merrill | Dec 2020 | A1 |
20200405521 | Glasroe | Dec 2020 | A1 |
20210008771 | Huber et al. | Jan 2021 | A1 |
20210009323 | Markarian et al. | Jan 2021 | A1 |
20210059853 | Davis | Mar 2021 | A1 |
20210061523 | Bytheway | Mar 2021 | A1 |
20210069005 | Sanchez | Mar 2021 | A1 |
20210069008 | Blabas et al. | Mar 2021 | A1 |
20210077993 | Nazareth et al. | Mar 2021 | A1 |
20210113749 | Radl et al. | Apr 2021 | A1 |
20210121318 | Pinlac | Apr 2021 | A1 |
20210137724 | Ecklund et al. | May 2021 | A1 |
20210154055 | Villarreal | May 2021 | A1 |
20210170079 | Radl et al. | Jun 2021 | A1 |
20210220162 | Jamison | Jul 2021 | A1 |
20210220163 | Mayrand | Jul 2021 | A1 |
20210228400 | Glithero | Jul 2021 | A1 |
20210228401 | Becker et al. | Jul 2021 | A1 |
20210228795 | Hughett | Jul 2021 | A1 |
20210229877 | Ragias et al. | Jul 2021 | A1 |
20210236323 | Austermann | Aug 2021 | A1 |
20210267787 | Nazemi | Sep 2021 | A1 |
20210275343 | Sanchez | Sep 2021 | A1 |
20210315727 | Jiang | Oct 2021 | A1 |
20210353450 | Sharma et al. | Nov 2021 | A1 |
20210361469 | Liu et al. | Nov 2021 | A1 |
20210369495 | Cheng | Dec 2021 | A1 |
20210386925 | Hartwell et al. | Dec 2021 | A1 |
20210393433 | Godinez et al. | Dec 2021 | A1 |
20220023091 | Ecklund et al. | Jan 2022 | A1 |
20220047410 | Walthall | Feb 2022 | A1 |
20220062027 | Mitchell et al. | Mar 2022 | A1 |
20220062029 | Johannes | Mar 2022 | A1 |
20220066825 | Saraf et al. | Mar 2022 | A1 |
20220071811 | Cheng | Mar 2022 | A1 |
20220071826 | Kulkarni et al. | Mar 2022 | A1 |
20220104965 | Vaninetti et al. | Apr 2022 | A1 |
20220104981 | Jones | Apr 2022 | A1 |
20220117774 | Meyer | Apr 2022 | A1 |
20220117775 | Jones | Apr 2022 | A1 |
20220133524 | Davis | May 2022 | A1 |
20220151817 | Mann | May 2022 | A1 |
20220218510 | Metzger et al. | Jul 2022 | A1 |
20220229053 | Levin et al. | Jul 2022 | A1 |
20220248836 | Cagle et al. | Aug 2022 | A1 |
20220257407 | Johannes | Aug 2022 | A1 |
20220265462 | Alder | Aug 2022 | A1 |
20220273482 | Johannes et al. | Sep 2022 | A1 |
20220280357 | Jagannathan | Sep 2022 | A1 |
20220313474 | Kriscovich et al. | Oct 2022 | A1 |
20220354685 | Davis | Nov 2022 | A1 |
20220370231 | Wang et al. | Nov 2022 | A1 |
20220370234 | Hughett et al. | Nov 2022 | A1 |
20220370237 | Parmar et al. | Nov 2022 | A1 |
20220387001 | Askenazi et al. | Dec 2022 | A1 |
20220395391 | Saunders et al. | Dec 2022 | A1 |
20230018845 | Lee | Jan 2023 | A1 |
20230020563 | Sharma et al. | Jan 2023 | A1 |
20230037159 | Brennan et al. | Feb 2023 | A1 |
20230062994 | Ecklund et al. | Mar 2023 | A1 |
20230089032 | Hughett et al. | Mar 2023 | A1 |
20230105001 | Whittome et al. | Apr 2023 | A1 |
20230138269 | Abdelal et al. | May 2023 | A1 |
20230145365 | Martin et al. | May 2023 | A1 |
20230277362 | Davis | Sep 2023 | A1 |
Number | Date | Country |
---|---|---|
2018216821 | Aug 2019 | AU |
2165286 | Sep 1999 | CA |
2354132 | Jun 2000 | CA |
2488867 | Aug 2007 | CA |
3050918 | Aug 2018 | CA |
3098571 | Nov 2019 | CA |
2269203 | Dec 1997 | CN |
1332620 | Jan 2002 | CN |
1533755 | Oct 2004 | CN |
1602825 | Apr 2005 | CN |
1720888 | Jan 2006 | CN |
2006026108 | Feb 2006 | CN |
2936204 | Aug 2007 | CN |
101262836 | Sep 2008 | CN |
102159159 | Aug 2011 | CN |
202184840 | Apr 2012 | CN |
102481441 | May 2012 | CN |
103533968 | Jan 2014 | CN |
103717180 | Apr 2014 | CN |
204562697 | Aug 2015 | CN |
105451693 | Mar 2016 | CN |
205849719 | Jan 2017 | CN |
107847384 | Mar 2018 | CN |
107920912 | Apr 2018 | CN |
209285902 | Aug 2019 | CN |
211198839 | Aug 2020 | CN |
114375187 | Apr 2022 | CN |
116096332 | May 2023 | CN |
1516466 | Jun 1969 | DE |
2721330 | Nov 1977 | DE |
2742298 | Mar 1978 | DE |
9407554.9 | May 1995 | DE |
4443710 | Jun 1995 | DE |
19619597 | Nov 1997 | DE |
102011103783 | Dec 2012 | DE |
202015104597 | Jul 2016 | DE |
9600118 | Nov 1996 | DK |
0032138 | Jul 1981 | EP |
0066070 | Dec 1982 | EP |
0274753 | Jul 1988 | EP |
0119143 | Nov 1988 | EP |
0610638 | Aug 1994 | EP |
0613355 | Sep 1994 | EP |
0613355 | Jan 1997 | EP |
0966936 | Dec 1999 | EP |
0987293 | Mar 2000 | EP |
1063953 | Jan 2001 | EP |
0653928 | Oct 2002 | EP |
1332738 | Aug 2003 | EP |
1382318 | Jan 2004 | EP |
1089684 | Oct 2004 | EP |
1616542 | Jan 2006 | EP |
1382318 | May 2006 | EP |
1063953 | Jan 2007 | EP |
1872752 | Jan 2008 | EP |
2180907 | May 2010 | EP |
2380532 | Oct 2011 | EP |
2389908 | Nov 2011 | EP |
2601916 | Jun 2013 | EP |
2676643 | Dec 2013 | EP |
2997950 | Mar 2016 | EP |
2879534 | Mar 2017 | EP |
3424471 | Jan 2019 | EP |
3169292 | Nov 2019 | EP |
3788992 | Mar 2021 | EP |
3576689 | Mar 2022 | EP |
3752110 | Mar 2022 | EP |
4025163 | Jul 2022 | EP |
1011517 | Dec 1965 | GB |
1467144 | Mar 1977 | GB |
2106395 | Apr 1983 | GB |
2106784 | Apr 1983 | GB |
2148126 | May 1985 | GB |
2171315 | Aug 1986 | GB |
2148126 | Jul 1987 | GB |
2191095 | Dec 1987 | GB |
2199750 | Jul 1988 | GB |
2260907 | May 1993 | GB |
2462267 | Feb 2010 | GB |
2469496 | Oct 2010 | GB |
2490327 | Oct 2012 | GB |
2507318 | Apr 2014 | GB |
201800009129 | Apr 2020 | IT |
S5410596 | Jan 1979 | JP |
S5410596 | May 1979 | JP |
S55155618 | Dec 1980 | JP |
S5888596 | Jun 1983 | JP |
S63107780 | Jul 1988 | JP |
H0267530 | Mar 1990 | JP |
H02103871 | Apr 1990 | JP |
H02131422 | May 1990 | JP |
H0460220 | Feb 1992 | JP |
H05123349 | May 1993 | JP |
H05123350 | May 1993 | JP |
H085630 | Jan 1996 | JP |
H1040141 | Feb 1998 | JP |
H10225430 | Aug 1998 | JP |
H11113946 | Apr 1999 | JP |
H11290365 | Oct 1999 | JP |
2000116690 | Apr 2000 | JP |
2000185068 | Jul 2000 | JP |
3087938 | Sep 2000 | JP |
2001054531 | Feb 2001 | JP |
2001070331 | Mar 2001 | JP |
2001276107 | Oct 2001 | JP |
2001276108 | Oct 2001 | JP |
2002028173 | Jan 2002 | JP |
2003505152 | Feb 2003 | JP |
2003180722 | Jul 2003 | JP |
2004130056 | Apr 2004 | JP |
2004267530 | Sep 2004 | JP |
2005066011 | Mar 2005 | JP |
2005066325 | Mar 2005 | JP |
2005518237 | Jun 2005 | JP |
3749097 | Dec 2005 | JP |
3123547 | Jun 2006 | JP |
2006136492 | Jun 2006 | JP |
2006204868 | Aug 2006 | JP |
2007044494 | Feb 2007 | JP |
3132659 | May 2007 | JP |
4039641 | Nov 2007 | JP |
2009509570 | Mar 2009 | JP |
2009101738 | Aug 2009 | JP |
2010081981 | Apr 2010 | JP |
4640772 | Dec 2010 | JP |
2010536439 | Dec 2010 | JP |
4747166 | May 2011 | JP |
2011087823 | May 2011 | JP |
4801218 | Aug 2011 | JP |
2011218130 | Nov 2011 | JP |
2011224070 | Nov 2011 | JP |
2012523869 | Oct 2012 | JP |
2013238608 | Nov 2013 | JP |
2014521960 | Aug 2014 | JP |
2015092945 | May 2015 | JP |
3198994 | Jul 2015 | JP |
2019525811 | Sep 2019 | JP |
2021120686 | Aug 2021 | JP |
200290061 | Sep 2002 | KR |
20030047451 | Jun 2003 | KR |
20140039485 | Apr 2014 | KR |
101432639 | Aug 2014 | KR |
20180106659 | Oct 2018 | KR |
20180108774 | Oct 2018 | KR |
2068717 | Jun 2013 | PT |
8101957 | Jul 1981 | WO |
8804558 | Jun 1988 | WO |
9104714 | Apr 1991 | WO |
9104714 | Jun 1991 | WO |
9220299 | Feb 1993 | WO |
9309736 | May 1993 | WO |
9309736 | Jun 1993 | WO |
9514448 | Jun 1995 | WO |
9600096 | Jan 1996 | WO |
9634636 | Nov 1996 | WO |
9817211 | Apr 1998 | WO |
9830336 | Jul 1998 | WO |
0000112 | Jan 2000 | WO |
0000113 | Jan 2000 | WO |
0025651 | May 2000 | WO |
0033773 | Jun 2000 | WO |
0057784 | Oct 2000 | WO |
0145618 | Jun 2001 | WO |
0145621 | Jun 2001 | WO |
02094160 | Nov 2002 | WO |
03013967 | Feb 2003 | WO |
03024824 | Mar 2003 | WO |
03055423 | Jul 2003 | WO |
03071931 | Sep 2003 | WO |
03079942 | Oct 2003 | WO |
03071931 | Feb 2004 | WO |
2004019836 | Mar 2004 | WO |
2004024046 | Mar 2004 | WO |
2005074571 | Sep 2005 | WO |
2005089687 | Sep 2005 | WO |
2005107661 | Nov 2005 | WO |
2006021220 | Mar 2006 | WO |
2007007845 | Jan 2007 | WO |
2007042823 | Apr 2007 | WO |
2007055651 | May 2007 | WO |
2006098950 | Nov 2007 | WO |
2007128156 | Feb 2008 | WO |
2008026106 | Mar 2008 | WO |
2008078117 | Jul 2008 | WO |
2008104019 | Sep 2008 | WO |
2008141471 | Nov 2008 | WO |
2009004368 | Jan 2009 | WO |
2009004369 | Jan 2009 | WO |
2009052496 | Apr 2009 | WO |
2009007702 | Jul 2009 | WO |
2010058192 | May 2010 | WO |
2010030122 | Jul 2010 | WO |
2010101915 | Jan 2011 | WO |
2011018132 | Feb 2011 | WO |
2011018133 | Feb 2011 | WO |
201 1024864 | Mar 2011 | WO |
2011054118 | May 2011 | WO |
2011079132 | Jun 2011 | WO |
2011107972 | Sep 2011 | WO |
2011108972 | Sep 2011 | WO |
2011117292 | Sep 2011 | WO |
2011123219 | Oct 2011 | WO |
2011132043 | Oct 2011 | WO |
2012012908 | Feb 2012 | WO |
2012065274 | May 2012 | WO |
2012097462 | Jul 2012 | WO |
2012098796 | Jul 2012 | WO |
2012101288 | Aug 2012 | WO |
2012175916 | Dec 2012 | WO |
2013018435 | Feb 2013 | WO |
2013033429 | Mar 2013 | WO |
2013055434 | Apr 2013 | WO |
2013082397 | Jun 2013 | WO |
2013103291 | Jul 2013 | WO |
2013131109 | Sep 2013 | WO |
2013167478 | Nov 2013 | WO |
2013177716 | Dec 2013 | WO |
2014041534 | Mar 2014 | WO |
2014046420 | Mar 2014 | WO |
2014118518 | Aug 2014 | WO |
2014160852 | Oct 2014 | WO |
2015023599 | Feb 2015 | WO |
2015052348 | Apr 2015 | WO |
2015068384 | May 2015 | WO |
2015169403 | Nov 2015 | WO |
2015170307 | Nov 2015 | WO |
2015197462 | Dec 2015 | WO |
2016051385 | Apr 2016 | WO |
2016055989 | Apr 2016 | WO |
2016071894 | May 2016 | WO |
2016103242 | Jun 2016 | WO |
2016116915 | Jul 2016 | WO |
2016124203 | Aug 2016 | WO |
2016139448 | Sep 2016 | WO |
2016166562 | Oct 2016 | WO |
2016167535 | Oct 2016 | WO |
2016191574 | Dec 2016 | WO |
2016200088 | Dec 2016 | WO |
2016200361 | Dec 2016 | WO |
2016204731 | Dec 2016 | WO |
2017075226 | May 2017 | WO |
2017152198 | Sep 2017 | WO |
2017153357 | Sep 2017 | WO |
2017162559 | Sep 2017 | WO |
2017205446 | Nov 2017 | WO |
2017209779 | Dec 2017 | WO |
2017210524 | Dec 2017 | WO |
2018022414 | Feb 2018 | WO |
2018044781 | Mar 2018 | WO |
2018056953 | Mar 2018 | WO |
2018090550 | May 2018 | WO |
2018138513 | Aug 2018 | WO |
2018144318 | Aug 2018 | WO |
2018144463 | Aug 2018 | WO |
2018150263 | Aug 2018 | WO |
2018150268 | Aug 2018 | WO |
2018152156 | Aug 2018 | WO |
2018183791 | Oct 2018 | WO |
2018150267 | Nov 2018 | WO |
2018235026 | Dec 2018 | WO |
2018235065 | Dec 2018 | WO |
2019004404 | Jan 2019 | WO |
2019065541 | Apr 2019 | WO |
2019096845 | May 2019 | WO |
2019150385 | Aug 2019 | WO |
2019161094 | Aug 2019 | WO |
2019188566 | Oct 2019 | WO |
2019190593 | Oct 2019 | WO |
2019212949 | Nov 2019 | WO |
2019212950 | Nov 2019 | WO |
2019212951 | Nov 2019 | WO |
2019212952 | Nov 2019 | WO |
2019212954 | Nov 2019 | WO |
2019212955 | Nov 2019 | WO |
2019212956 | Nov 2019 | WO |
2019214787 | Nov 2019 | WO |
2019214788 | Nov 2019 | WO |
2020000994 | Jan 2020 | WO |
2020020618 | Jan 2020 | WO |
2020038822 | Feb 2020 | WO |
2020088409 | May 2020 | WO |
2020049394 | Jun 2020 | WO |
2020120657 | Jun 2020 | WO |
2020152575 | Jul 2020 | WO |
2020182923 | Sep 2020 | WO |
2020204967 | Oct 2020 | WO |
2020209898 | Oct 2020 | WO |
2020242790 | Dec 2020 | WO |
2020251893 | Dec 2020 | WO |
2020256865 | Dec 2020 | WO |
2021007144 | Jan 2021 | WO |
2021007345 | Jan 2021 | WO |
2021010844 | Jan 2021 | WO |
2021016026 | Jan 2021 | WO |
2021016300 | Jan 2021 | WO |
2021025919 | Feb 2021 | WO |
2021034886 | Feb 2021 | WO |
2021041123 | Mar 2021 | WO |
2021086868 | May 2021 | WO |
2021094352 | May 2021 | WO |
2021102296 | May 2021 | WO |
2021138411 | Jul 2021 | WO |
2021138414 | Jul 2021 | WO |
2021155206 | Aug 2021 | WO |
2021173436 | Sep 2021 | WO |
2021195384 | Sep 2021 | WO |
2021207621 | Oct 2021 | WO |
2021211568 | Oct 2021 | WO |
2021216419 | Oct 2021 | WO |
2021216422 | Oct 2021 | WO |
2021247523 | Dec 2021 | WO |
2021257202 | Dec 2021 | WO |
2022006256 | Jan 2022 | WO |
2022031943 | Feb 2022 | WO |
2022035745 | Feb 2022 | WO |
2022076427 | Apr 2022 | WO |
2022086898 | Apr 2022 | WO |
2022098536 | May 2022 | WO |
2022125685 | Jun 2022 | WO |
2022140545 | Jun 2022 | WO |
2022150360 | Jul 2022 | WO |
2022150463 | Jul 2022 | WO |
2022159392 | Jul 2022 | WO |
2022170182 | Aug 2022 | WO |
2022182385 | Sep 2022 | WO |
2022192188 | Sep 2022 | WO |
2022192347 | Sep 2022 | WO |
2023014641 | Feb 2023 | WO |
2023038945 | Mar 2023 | WO |
2023038950 | Mar 2023 | WO |
2023049175 | Mar 2023 | WO |
Entry |
---|
US 9,908,683 B2, 03/2018, Sandhausen et al. (withdrawn) |
Advisory Action for U.S. Appl. No. 16/905,400 dated Jun. 9, 2021. |
Final Office Action for U.S. Appl. No. 16/899,956 dated Apr. 19, 2021. |
Final Office Action for U.S. Appl. No. 16/905,400 dated Apr. 6, 2021. |
Final Office Action for U.S. Appl. No. 17/088,272 dated May 25, 2021. |
Notice of Allowance for U.S. Appl. No. 14/952,591 dated Apr. 5, 2021. |
Notice of Allowance for U.S. Appl. No. 29/624,661 dated Apr. 28, 2021. |
Notice of Allowance for U.S. Appl. No. 29/694,002 dated Apr. 29, 2021. |
Restriction Requirement for U.S. Appl. No. 16/478,180 dated May 25, 2021. |
U.S. Appl. No. 17/330,657 dated May 26, 2021 |
Boehringer CareDry System—Second Generation for Non-Invasive Urinary Management for Females, Mar. 2021, 3 pgs. |
Advisory Action for U.S. Appl. No. 14/722,613 dated Mar. 4, 2019. |
Advisory Action for U.S. Appl. No. 14/952,591 dated Jun. 1, 2018. |
Advisory Action for U.S. Appl. No. 15/238,427 dated Apr. 10, 2019. |
Corrected International Search Report and Written Opinion for International Application No. PCT/US2017/043025 dated Jan. 11, 2018. |
Corrected Notice of Allowability for U.S. Appl. No. 15/221,106 dated Jul. 2, 2019. |
Final Office Action for U.S. Appl. No. 14/722,613 dated Nov. 29, 2018. |
Final Office Action for U.S. Appl. No. 14/947,759 dated Apr. 8, 2016. |
Final Office Action for U.S. Appl. No. 14/952,591 dated Feb. 23, 2018. |
Final Office Action for U.S. Appl. No. 14/952,591 dated Nov. 1, 2019. |
Final Office Action for U.S. Appl. No. 14/952,591 dated Nov. 27, 2020. |
Final Office Action for U.S. Appl. No. 15/171,968 dated Feb. 14, 2020. |
Final Office Action for U.S. Appl. No. 15/171,968 dated Mar. 19, 2019. |
Final Office Action for U.S. Appl. No. 15/221,106 dated Jan. 23, 2019. |
Final Office Action for U.S. Appl. No. 15/238,427 dated Jan. 2, 2019. |
Final Office Action for U.S. Appl. No. 15/260,103 dated Feb. 14, 2019. |
Final Office Action for U.S. Appl. No. 15/612,325 dated Sep. 17, 2020. |
Final Office Action for U.S. Appl. No. 29/624,661 dated Feb. 18, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2016/049274 dated Dec. 1, 2016. |
International Search Report and Written Opinion from International Application No. PCT/US2017/035625 dated Aug. 15, 2017. |
International Search Report and Written Opinion from International Application No. PCT/US2017/043025 dated Oct. 18, 2017. |
International Search Report and Written Opinion from International Application No. PCT/US2018/015968 dated Apr. 6, 2018. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029608 dated Sep. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029609 dated Sep. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029610 dated Sep. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029611 dated Jul. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029613 dated Jul. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029614 dated Sep. 26, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029616 dated Aug. 30, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2020/023572 dated Jul. 6, 2020. |
Issue Notification for U.S. Appl. No. 15/221,106 dated Jul. 24, 2019. |
Issue Notification for U.S. Appl. No. 15/238,427 dated Jul. 24, 2019. |
Issue Notification for U.S. Appl. No. 15/260,103 dated Aug. 7, 2019. |
Issue Notification for U.S. Appl. No. 15/611,587 dated Feb. 20, 2019. |
Non-Final Office Action for U.S. Appl. No. 14/722,613 dated Jun. 13, 2019. |
Non-Final Office Action for U.S. Appl. No. 14/947,759, dated Mar. 17, 2016. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Aug. 1, 2017. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Mar. 20, 2020. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Mar. 21, 2019. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Sep. 28, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/171,968 dated May 11, 2020. |
Non-Final Office Action for U.S. Appl. No. 15/171,968 dated Aug. 20, 2019. |
Non-Final Office Action for U.S. Appl. No. 15/171,968 dated Jun. 12, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/221,106 dated Jun. 5, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/238,427 dated Aug. 8, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/260,103 dated Sep. 26, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/611,587 dated Dec. 29, 2017. |
Non-Final Office Action for U.S. Appl. No. 15/611,587 dated Jul. 13, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/612,325 dated Mar. 19, 2020. |
Non-Final Office Action for U.S. Appl. No. 16/899,956 dated Oct. 16, 2020. |
Non-Final Office Action for U.S. Appl. No. 16/904,868 dated Nov. 25, 2020. |
Non-Final Office Action for U.S. Appl. No. 16/905,400 dated Dec. 2, 2020. |
Non-Final Office Action for U.S. Appl. No. 29/624,661 dated Jul. 18, 2019. |
Non-Final Office Action for U.S. Appl. No. 29/694,002 dated Jun. 24, 2020. |
Notice of Allowance for U.S. Appl. No. 15/171,968 dated Nov. 6, 2020. |
Notice of Allowance for U.S. Appl. No. 15/221,106 dated May 1, 2019. |
Notice of Allowance for U.S. Appl. No. 15/238,427 dated May 23, 2019. |
Notice of Allowance for U.S. Appl. No. 15/260,103 dated Jun. 7, 2019. |
Notice of Allowance for U.S. Appl. No. 15/611,587 dated Dec. 21, 2018. |
Notice of Allowance for U.S. Appl. No. 15/612,325 dated Jan. 21, 2021. |
Notice of Allowance for U.S. Appl. No. 29/624,661 dated Jul. 10, 2020. |
Notice of Allowance for U.S. Appl. No. 29/624,661 dated May 14, 2020. |
Notice of Allowance for U.S. Appl. No. 29/624,661 dated Sep. 29, 2020. |
Notice of Allowance for U.S. Appl. No. 29/694,002 dated Oct. 16, 2020. |
U.S. Appl. No. 15/171,968, filed Jun. 2, 2016. |
U.S. Appl. No. 15/221,106, filed Jul. 27, 2016. |
U.S. Appl. No. 15/260,103, filed Sep. 8, 2016. |
U.S. Appl. No. 15/611,587, filed Jun. 1, 2017. |
U.S. Appl. No. 15/612,325, filed Jun. 2, 2017. |
U.S. Appl. No. 16/369,676, filed Mar. 29, 2019. |
U.S. Appl. No. 16/433,773, filed Jun. 6, 2019. |
U.S. Appl. No. 16/449,039, filed Jun. 21, 2019. |
U.S. Appl. No. 16/452,145, filed Jun. 25, 2019. |
U.S. Appl. No. 16/452,258, filed Jun. 25, 2019. |
U.S. Appl. No. 16/478,180, filed Jul. 16, 2019. |
U.S. Appl. No. 16/904,868, filed Jun. 18, 2020. |
U.S. Appl. No. 16/905,400, filed Jun. 18, 2020. |
U.S. Appl. No. 17/051,550, filed Oct. 29, 2020. |
U.S. Appl. No. 17/051,585, filed Oct. 29, 2020. |
U.S. Appl. No. 17/051,600, filed Oct. 29, 2020. |
U.S. Appl. No. 17/088,272, filed Nov. 3, 2020. |
U.S. Appl. No. 29/741,751, filed Jul. 15, 2020. |
U.S. Appl. No. 62/452,437, filed Jan. 31, 2017. |
U.S. Appl. No. 62/665,297, filed May 1, 2018. |
U.S. Appl. No. 62/665,302, filed May 1, 2018. |
U.S. Appl. No. 62/665,317, filed May 1, 2018. |
U.S. Appl. No. 62/665,321, filed May 1, 2018. |
U.S. Appl. No. 62/665,331, filed May 1, 2018. |
U.S. Appl. No. 62/665,335, filed May 1, 2018. |
U.S. Appl. No. 62/853,889, filed May 29, 2019. |
U.S. Appl. No. 62/873,045, filed Jul. 11, 2019. |
U.S. Appl. No. 62/873,048, filed Jul. 11, 2019. |
U.S. Appl. No. 62/994,912, filed Mar. 26, 2020. |
U.S. Appl. No. 63/011,445, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,487, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,571, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,657, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,760, filed Apr. 17, 2020. |
U.S. Appl. No. 63/012,347, filed Apr. 20, 2020. |
U.S. Appl. No. 63/012,384, filed Apr. 20, 2020. |
U.S. Appl. No. 63/061,241, filed Aug. 5, 2020. |
U.S. Appl. No. 63/061,244, filed Aug. 5, 2020. |
U.S. Appl. No. 63/061,834, filed Aug. 6, 2020. |
U.S. Appl. No. 63/064,017, filed Aug. 11, 2020. |
U.S. Appl. No. 63/064,126 filed Aug. 11, 2020. |
U.S. Appl. No. 63/071,438, filed Aug. 28, 2020. |
U.S. Appl. No. 63/074,051, filed Sep. 3, 2020. |
U.S. Appl. No. 63/074,066, filed Sep. 3, 2020. |
U.S. Appl. No. 63/076,032, filed Sep. 9, 2020. |
U.S. Appl. No. 63/076,474, filed Sep. 10, 2020. |
U.S. Appl. No. 63/076,477, filed Sep. 10, 2020. |
U.S. Appl. No. 63/082,261, filed Sep. 23, 2020. |
U.S. Appl. No. 63/088,506, filed Oct. 7, 2020. |
U.S. Appl. No. 63/088,511, filed Oct. 7, 2020. |
U.S. Appl. No. 63/094,464, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,594, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,608, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,626, filed Oct. 21, 2020. |
Defendant and Counterclaim Plaintiff Sage Products, LLC's Answer, Defenses, and Counterclaims to Plaintiff's Amended Complaint, Nov. 1, 2019. |
Sage's Initial Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508; 10,226,375; and 10,390,989, May 29, 2020, 193 pages. |
Sage's Supplemental and Initial Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508; 10,226,375; 10,390,989 and Initial Invalidity Contentions Regarding U.S. Pat. No. 10,376,407, Aug. 21, 2020, 277 pages. |
Sage's Second Supplemental Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508, 10,226,375, 10,390,989, and 10,376,407, 292 pages. |
Excerpts from the 508 (U.S. Pat. No. 8,278,508) Patent's Prosecution History, 2020, 99 pages. |
Plaintiff's Opening Claim Construction Brief, Case No. 19-1508-MN, Oct. 16, 2020, 26 pages. |
Plaintiff's Identification of Claim Terms and Proposed Constructions, Case No. 19-1508-MN, 3 pages. |
PureWick's Response to Interrogatory No. 9 in PureWick, LLC v. Sage Products, LLC, Case No. 19-1508-MN, Mar. 23, 2020, 6 pages. |
Sage's Preliminary Identification of Claim Elements and Proposed Constructions for U.S. Pat. Nos. 8,287,508, 10,226,376, 10,390,989 and 10,376,407, Case No. 19-1508-MN, 7 pages. |
Corrected Certificate of Service, Case No. IPR2020-01426, U.S. Pat. No. 8,287,508, 2020, 2 pages. |
Declaration of Diane K. Newman Curriculum Vitae, Petition for Interparties Review, 2020, pp. 1-199. |
“3 Devices Take Top Honors in Dare-To-Dream Medtech Design Contest”, R+D Digest, Nov. 2013, 1 page. |
“Advanced Mission Extender Device (AMDX) Products”, Omni Medical Systems, Inc., 15 pages. |
“AMXD Control Starter Kit Brochure”, https://www.omnimedicalsys.com/index.php?page=products, Omni Medical, 8 pages. |
“AMXDmax In-Flight Bladder Relief”, Omni Medical; Omni Medical Systems, Inc., 2015. |
“AMXDX—Advanced Mission Extender Device Brochure”, Omni Medical, Omni Brochure—http://www.omnimedicalsys.com/uploads/AMXDFixedWing.pdf, 2 pages. |
“How Period Panties Work”, www.shethinx.com/pages/thinx-itworks, 2020, 10 pages. |
“In Flight Bladder Relief”, Omni Medical, Omni Presentation https://www.omnimedicalsys.com/uploads/AMXDmax_HSD.pdf, 14 pages. |
“Research and Development Work Relating to Assistive Technology Jun. 2005”, British Department of Health, Nov. 2006, 40 pages. |
“Step by Step How Ur24 WorksHome”, http://medicalpatentur24.com, last accessed Dec. 6, 2017, Aug. 30, 2017, 4 pages. |
“Underwear that absorbs your period”, Thinx!, https://www.shethinx.com/pages/thinx-it-works last accessed Jun. 24, 2020, 7 pages. |
“User & Maintenance Guide”, Omni Medical, 2007, 16 pages. |
“Winners Announced for Dare-to-Dream Medtech Design Challenge”, https://www.mddionline.com/design-engineering/winners-announced-dare-dream-medtech-design-challenge, MD&DI, 2014, 4 pages. |
Hollister, Female Urinary and Pouch and Male Urinary Pouch Brochure, 2011, 1 page. |
Hollister, “Male Urinary Pouch External Collection Device”, http://www.hollister.com/en/products/Continence-Care-Products/Urine-Collectors/Urine-Collection-Accessories/Male-Urinary-Pouch-External-Collection-Device, last accessed Feb. 8, 2018. |
Hollister, “Retracted Penis Pouch by Hollister”, Vitality Medical.com, https://www.vitalitymedical.com/hollister-retracted-penis-pouch.html last accessed Jun. 24, 2020, 6 pages. |
Macaulay, et al., “A Noninvasive Continence Management System: Development and Evaluation of a Novel Toileting Device for Women”, The Wound, Ostomy and Continence Nurses Society, vol. 34 No. 6, 2007, pp. 641-648. |
Newman, et al., “The Urinary Incontinence Sourcebook”, Petition for Interparties Review, 1997, 23 pages. |
Newton, et al., “Measuring Safety, Effectiveness and Ease of Use of PureWick in the Management of Urinary Incontinence in Bedbound Women: Case Studies”, Jan. 8, 2016, 11 pages. |
Parmar, “10 Finalists Chosen for Dare-to-Dream Medtech Design Challenge (PureWick)”, Design Services, Nov. 10, 2014, 3 pages. |
Purewick, “Incontinence Relief for Women”, Presentation, Sep. 23, 2015, 7 pages. |
Pytlik, “Super Absorbent Polymers”, University of Buffalo, http://www.courses.sens.buffalo.edu/ce435/Diapers/Diapers.html, accessed on Feb. 17, 2017. |
Sachtman, “New Relief for Pilots? It Depends”, Wired, https://www.wired.com/2008/05/pilot-relief/, 2008, 2 pages. |
Corrected Notice of Allowability for U.S. Appl. No. 15/612,325 dated Mar. 17, 2021. |
Final Office Action for U.S. Appl. No. 16/904,868 dated Mar. 26, 2021. |
Issue Notification for U.S. Appl. No. 15/171,968 dated Mar. 3, 2021. |
Issue Notification for U.S. Appl. No. 15/612,325 dated Mar. 24, 2021. |
Notice of Allowance for U.S. Appl. No. 15/171,968 dated Feb. 16, 2021. |
Notice of Allowance for U.S. Appl. No. 15/612,325 dated Feb. 19, 2021. |
Notice of Allowance for U.S. Appl. No. 29/694,002 dated Jan. 29, 2021. |
Notice to File Missing Parts for U.S. Appl. No. 17/179,116 dated Mar. 3, 2021. |
U.S. Appl. No. 17/179,116, filed Feb. 18, 2021. |
Memorandum Order, Feb. 2021, 14 pgs. |
Decision Granting Institution of Inter Partes Review for U.S. Pat. No. 8,287,508, Case No. 2020-01426, Feb. 17, 2021, 39 pages. |
Advisory Action for U.S. Appl. No. 16/245,726 dated Apr. 19, 2023. |
Advisory Action for U.S. Appl. No. 16/369,676 dated Mar. 24, 2023. |
Advisory Action for U.S. Appl. No. 16/433,773 dated Feb. 15, 2023. |
Advisory Action for U.S. Appl. No. 16/452,258 dated Oct. 26, 2022. |
Advisory Action for U.S. Appl. No. 16/478,180 dated Sep. 21, 2022. |
Advisory Action for U.S. Appl. No. 16/478,180 dated Sep. 7, 2023. |
Advisory Action for U.S. Appl. No. 16/899,956 dated Jul. 9, 2021. |
Advisory Action for U.S. Appl. No. 16/904,868 dated Jul. 2, 2021. |
Advisory Action for U.S. Appl. No. 16/904,868 dated Jun. 15, 2022. |
Advisory Action for U.S. Appl. No. 16/905,400 dated Feb. 16, 2022. |
Advisory Action for U.S. Appl. No. 17/051,550 dated Sep. 8, 2023. |
Advisory Action for U.S. Appl. No. 17/444,792 dated Aug. 25, 2023. |
Advisory Action for U.S. Appl. No. 17/662,700 dated Jan. 30, 2023. |
Corrected Notice of Allowability for U.S. Appl. No. 17/330,657 dated Dec. 9, 2021. |
Final Office Action for U.S. Appl. No. 16/245,726 dated Nov. 25, 2022. |
Final Office Action for U.S. Appl. No. 16/369,676 dated Aug. 31, 2023. |
Final Office Action for U.S. Appl. No. 16/369,676 dated Dec. 5, 2022. |
Final Office Action for U.S. Appl. No. 16/433,773 dated Oct. 25, 2022. |
Final Office Action for U.S. Appl. No. 16/449,039 dated Aug. 1, 2022. |
Final Office Action for U.S. Appl. No. 16/452,145 dated Mar. 25, 2022. |
Final Office Action for U.S. Appl. No. 16/452,258 dated Jun. 14, 2022. |
Final Office Action for U.S. Appl. No. 16/478,180 dated Jun. 22, 2022. |
Final Office Action for U.S. Appl. No. 16/478, 180 dated May 31, 2023. |
Final Office Action for U.S. Appl. No. 16/904,868 dated Mar. 10, 2022. |
Final Office Action for U.S. Appl. No. 16/905,400 dated Dec. 9, 2021. |
Final Office Action for U.S. Appl. No. 17/051,399 dated Mar. 9, 2023. |
Final Office Action for U.S. Appl. No. 17/051,550 dated May 23, 2023. |
Final Office Action for U.S. Appl. No. 17/051,585 dated Jul. 27, 2023. |
Final Office Action for U.S. Appl. No. 17/444,792 dated Jun. 15, 2023. |
Final Office Action for U.S. Appl. No. 17/446,256 dated Sep. 19, 2023. |
Final Office Action for U.S. Appl. No. 17/448,811 dated Aug. 3, 2023. |
Final Office Action for U.S. Appl. No. 17/451,345 dated May 3, 2023. |
Final Office Action for U.S. Appl. No. 17/653,137 dated Sep. 21, 2023. |
Final Office Action for U.S. Appl. No. 17/655,464 dated Sep. 1, 2023. |
Final Office Action for U.S. Appl. No. 17/662,700 dated Sep. 30, 2022. |
International Search Report and Written Opinion from International Application No. PCT/IB2021/057173 dated Nov. 5, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/033064 dated Aug. 31, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/033122 dated Aug. 31, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/040860 dated Oct. 2, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/041242 dated Nov. 17, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/041249 dated Oct. 2, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/042262 dated Oct. 14, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/043059 dated Oct. 6, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/044024 dated Nov. 12, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/046914 dated Dec. 1, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/055680 dated Dec. 15, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/057562 dated Jan. 27, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/061563 dated Feb. 19, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/065234 dated Apr. 12, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/067451 dated Mar. 25, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/067454 dated Mar. 29, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/067455 dated Mar. 26, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/015024 dated May 18, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/015787 dated May 27, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/023001 dated Jun. 21, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/024162 dated Jul. 8, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/026607 dated Jul. 29, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027061 dated Jul. 19, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027104 dated Jul. 6, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027314 dated Jul. 6, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027422 dated Aug. 12, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027425 dated Aug. 11, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027913 dated Jul. 12, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027917 dated Aug. 19, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/039866 dated Oct. 7, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/043893 dated Nov. 22, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/044699 dated Nov. 22, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/045188 dated Jan. 26, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/047536 dated Dec. 23, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/048211 dated Dec. 22, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/048661 dated Feb. 14, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/049404 dated Jan. 18, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/051456 dated Jan. 19, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/053593 dated Apr. 11, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/055515 dated Jan. 28, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/056566 dated Feb. 11, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/060993 dated Mar. 18, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/062440 dated Mar. 28, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/011108 dated Apr. 22, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/011281 dated Apr. 25, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/011419 dated Jun. 7, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/011421 dated Jun. 13, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/012794 dated May 3, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/014285 dated Sep. 28, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/014749 dated Sep. 28, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015026 dated Oct. 31, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015045 dated Sep. 9, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015073 dated Sep. 8, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015418 dated Nov. 11, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015420 dated Nov. 18, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015471 dated May 16, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015492 dated Apr. 26, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015781 dated May 6, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/016942 dated Jun. 8, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/018159 dated Dec. 12, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/018170 dated May 31, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/019254 dated Jun. 7, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/019480 dated Jun. 13, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/021103 dated Jun. 23, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/022111 dated Oct. 26, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/023594 dated Jul. 12, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/026667 dated Aug. 22, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/030685 dated Oct. 31, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/031032 dated Sep. 9, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/032424 dated Oct. 11, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/034457 dated Oct. 12, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/034744 dated Dec. 9, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/039018 dated Jan. 10, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/039022 dated Jan. 10, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/039711 dated Jan. 12, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/039714 dated Nov. 22, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/041085 dated Mar. 16, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/041688 dated Nov. 21, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/042719 dated Dec. 5, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/042725 dated Dec. 19, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/043818 dated Mar. 24, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/044107 dated Dec. 23, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/044208 dated May 8, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/044212 dated Jan. 20, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/044243 dated Feb. 24, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/049300 dated Jun. 6, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/050909 dated Jul. 24, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2023/012696 dated Jul. 6, 2023. |
Issue Notification for U.S. Appl. No. 14/952,591 dated Jul. 28, 2021. |
Issue Notification for U.S. Appl. No. 16/899,956 dated Mar. 29, 2023. |
Issue Notification for U.S. Appl. No. 16/905,400 dated Nov. 30, 2022. |
Issue Notification for U.S. Appl. No. 17/088,272 dated Jun. 15, 2022. |
Issue Notification for U.S. Appl. No. 17/330,657 dated Jun. 22, 2022. |
Issue Notification for U.S. Appl. No. 29/624,661 dated Aug. 4, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/245,726 dated Jan. 21, 2022. |
Non-Final Office Action for U.S. Appl. No. 16/369,676 dated Mar. 31, 2022. |
Non-Final Office Action for U.S. Appl. No. 16/433,773 dated Apr. 11, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/433,773 dated Apr. 21, 2022. |
Non-Final Office Action for U.S. Appl. No. 16/449,039 dated Apr. 27, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/449,039 dated Dec. 8, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/452,145 dated Mar. 28, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/452,145 dated Sep. 28, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/452,258 dated Apr. 26, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/452,258 dated Sep. 28, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/478,180 dated Dec. 20, 2022. |
Non-Final Office Action for U.S. Appl. No. 16/478,180 dated Oct. 22, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/899,956 dated Sep. 2, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/904,868 dated Mar. 15, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/904,868 dated Oct. 5, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/905,400 dated Apr. 27, 2022. |
Non-Final Office Action for U.S. Appl. No. 16/905,400 dated Jul. 22, 2021. |
Non-Final Office Action for U.S. Appl. No. 17/051,399 dated Aug. 18, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/051,550 dated Dec. 15, 2022. |
Non-Final Office Action for U.S. Appl. No. 17/051,585 dated Mar. 29, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/179,116 dated Mar. 24, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/326,980 dated Jul. 11, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/330,657 dated Aug. 11, 2021. |
Non-Final Office Action for U.S. Appl. No. 17/444,792 dated Feb. 10, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/446,256 dated Apr. 13, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/446,654 dated Sep. 8, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/448,811 dated Mar. 1, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/450,864 dated May 10, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/451,345 dated Dec. 7, 2022. |
Non-Final Office Action for U.S. Appl. No. 17/451,354 dated May 3, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/453,260 dated Mar. 14, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/501,591 dated Apr. 25, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/646,771 dated Jul. 5, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/653,137 dated Apr. 7, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/655,464 dated Mar. 14, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/657,474 dated Sep. 12, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/661,090 dated Jul. 6, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/662,700 dated Jul. 22, 2022. |
Non-Final Office Action for U.S. Appl. No. 17/663,330 dated Jun. 29, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/664,487 dated Jun. 8, 2023. |
Non-Final Office Action for U.S. Appl. No. 18/139,523 dated Aug. 17, 2023. |
Non-Final Office Action for U.S. Appl. No. 18/140,751 dated Sep. 14, 2023. |
Non-Final Office Action for U.S. Appl. No. 29/741,751 dated Jan. 18, 2022. |
Notice of Allowance for U.S. Appl. No. 14/952,591 dated Jul. 8, 2021. |
Notice of Allowance for U.S. Appl. No. 16/245,726 dated Jul. 6, 2023. |
Notice of Allowance for U.S. Appl. No. 16/449,039 dated Dec. 15, 2022. |
Notice of Allowance for U.S. Appl. No. 16/899,956 dated Apr. 19, 2022. |
Notice of Allowance for U.S. Appl. No. 16/899,956 dated Aug. 10, 2022. |
Notice of Allowance for U.S. Appl. No. 16/899,956 dated Dec. 1, 2022. |
Notice of Allowance for U.S. Appl. No. 16/899,956 dated Dec. 29, 2021. |
Notice of Allowance for U.S. Appl. No. 16/905,400 dated Aug. 17, 2022. |
Notice of Allowance for U.S. Appl. No. 17/088,272 dated Aug. 5, 2021. |
Notice of Allowance for U.S. Appl. No. 17/088,272 dated Mar. 4, 2022. |
Notice of Allowance for U.S. Appl. No. 17/088,272 dated Nov. 24, 2021. |
Notice of Allowance for U.S. Appl. No. 17/330,657 dated Mar. 16, 2022. |
Notice of Allowance for U.S. Appl. No. 17/330,657 dated Nov. 26, 2021. |
Notice of Allowance for U.S. Appl. No. 17/461,036 dated Feb. 22, 2023. |
Notice of Allowance for U.S. Appl. No. 17/461,036 dated Jun. 30, 2023. |
Notice of Allowance for U.S. Appl. No. 17/461,036 dated Oct. 6, 2022. |
Notice of Allowance for U.S. Appl. No. 17/662,700 dated Jul. 28, 2023. |
Notice of Allowance for U.S. Appl. No. 17/662,700 dated Mar. 28, 2023. |
Notice of Allowance for U.S. Appl. No. 17/663,046 dated Jan. 30, 2023. |
Notice of Allowance for U.S. Appl. No. 18/299,788 dated Jul. 24, 2023. |
Notice of Allowance for U.S. Appl. No. 29/741,751 dated Jun. 9, 2022. |
Restriction Requirement for U.S. Appl. No. 16/433,773 dated Dec. 7, 2021. |
Restriction Requirement for U.S. Appl. No. 17/051,600 dated Sep. 21, 2023. |
Restriction Requirement for U.S. Appl. No. 17/326,980 dated Mar. 20, 2023. |
Restriction Requirement for U.S. Appl. No. 17/446,256 dated Jan. 23, 2023. |
Restriction Requirement for U.S. Appl. No. 17/645,821 dated Jul. 12, 2023. |
Restriction Requirement for U.S. Appl. No. 17/646,771 dated Apr. 6, 2023. |
Restriction Requirement for U.S. Appl. No. 17/657,474 dated Jun. 30, 2023. |
Text Messages to Lorena Eckert Re Prototype PureWick Holder dated Apr. 16, 2022. |
U.S. Appl. No. 14/625,469, filed Feb. 28, 2015. |
U.S. Appl. No. 14/947,759, filed Nov. 20, 2015. |
U.S. Appl. No. 14/952,591, filed Nov. 25, 2015. |
U.S. Appl. No. 15/384,196 filed Dec. 19, 2016. |
U.S. Appl. No. 16/245,726, filed Jan. 11, 2019. |
U.S. Appl. No. 17/378,015, filed Jul. 16, 2021. |
U.S. Appl. No. 17/394,055, filed Aug. 4, 2021. |
U.S. Appl. No. 17/444,825, filed Aug. 10, 2021. |
U.S. Appl. No. 17/446,256, filed Aug. 27, 2021. |
U.S. Appl. No. 17/446,654, filed Sep. 1, 2021. |
U.S. Appl. No. 17/447,123, filed Sep. 8, 2021. |
U.S. Appl. No. 17/450,864, filed Oct. 14, 2021. |
U.S. Appl. No. 17/451,345, filed Oct. 19, 2021. |
U.S. Appl. No. 17/451,354, filed Oct. 19, 2021. |
U.S. Appl. No. 17/453,260, filed Nov. 2, 2021. |
U.S. Appl. No. 17/453,560, filed Nov. 4, 2021. |
U.S. Appl. No. 17/461,036 dated Aug. 30, 2021. |
U.S. Appl. No. 17/501,591, filed Oct. 14, 2021. |
U.S. Appl. No. 17/595,747, filed Nov. 23, 2021. |
U.S. Appl. No. 17/597,408, filed Jan. 5, 2022. |
U.S. Appl. No. 17/597,673, filed Jan. 18, 2022. |
U.S. Appl. No. 17/614,173, filed Nov. 24, 2021. |
U.S. Appl. No. 17/631,619, filed Jan. 31, 2022. |
U.S. Appl. No. 17/645,821, filed Dec. 23, 2021. |
U.S. Appl. No. 17/646,771, filed Jan. 3, 2022. |
U.S. Appl. No. 17/653,314, filed Mar. 3, 2022. |
U.S. Appl. No. 17/653,920, filed Mar. 8, 2022. |
U.S. Appl. No. 17/655,464, filed Mar. 18, 2022. |
U.S. Appl. No. 17/657,474, filed Mar. 31, 2022. |
U.S. Appl. No. 17/661,090, filed Apr. 28, 2022. |
U.S. Appl. No. 17/662,700, filed May 10, 2022. |
U.S. Appl. No. 17/663,046, filed May 12, 2022. |
U.S. Appl. No. 17/664,487, filed May 23, 2022. |
U.S. Appl. No. 17/664,914, filed May 25, 2022. |
U.S. Appl. No. 17/749,340, filed May 20, 2022. |
U.S. Appl. No. 17/754,736, filed Apr. 11, 2022. |
U.S. Appl. No. 17/756,201, filed May 19, 2022. |
U.S. Appl. No. 17/758,152, filed Jun. 29, 2022. |
U.S. Appl. No. 17/758,316, filed Jul. 1, 2022. |
U.S. Appl. No. 17/759,697, filed Jul. 28, 2022. |
U.S. Appl. No. 17/878,268, filed Aug. 1, 2022. |
U.S. Appl. No. 17/907,125, filed Sep. 23, 2022. |
U.S. Appl. No. 17/912,147, filed Sep. 16, 2022. |
U.S. Appl. No. 17/929,887, filed Sep. 6, 2022. |
U.S. Appl. No. 17/930,238, filed Sep. 7, 2022. |
U.S. Appl. No. 17/933,590, filed Sep. 20, 2022. |
U.S. Appl. No. 17/996,064, filed Oct. 12, 2022. |
U.S. Appl. No. 17/996,155, filed Oct. 13, 2022. |
U.S. Appl. No. 17/996,253, filed Oct. 14, 2022. |
U.S. Appl. No. 17/996,468, filed Oct. 18, 2022. |
U.S. Appl. No. 17/996,556, filed Oct. 19, 2022. |
U.S. Appl. No. 18/003,029, filed Dec. 22, 2022. |
U.S. Appl. No. 18/006,807, filed Jan. 25, 2023. |
U.S. Appl. No. 18/007,105, filed Jan. 27, 2023. |
U.S. Appl. No. 18/041,109, filed Feb. 9, 2023. |
U.S. Appl. No. 18/042,842, filed Feb. 24, 2023. |
U.S. Appl. No. 18/043,618, filed Mar. 1, 2023. |
U.S. Appl. No. 18/115,444, filed Feb. 28, 2023. |
U.S. Appl. No. 18/134,857, filed Apr. 14, 2023. |
U.S. Appl. No. 18/140,163, filed Apr. 27, 2023. |
U.S. Appl. No. 18/140,751, filed Apr. 28, 2023. |
U.S. Appl. No. 18/164,800, filed Feb. 6, 2023. |
U.S. Appl. No. 18/198,464, filed May 17, 2023. |
U.S. Appl. No. 18/246,121, filed Mar. 21, 2023. |
U.S. Appl. No. 18/247,986, filed Apr. 5, 2023. |
U.S. Appl. No. 18/259,626, filed Jun. 28, 2023. |
U.S. Appl. No. 18/260,122, filed Jun. 30, 2023. |
U.S. Appl. No. 18/260,391, filed Jul. 5, 2023. |
U.S. Appl. No. 18/260,394, filed Jul. 5, 2023. |
U.S. Appl. No. 18/263,800, filed Aug. 1, 2023. |
U.S. Appl. No. 18/264,004, filed Aug. 2, 2023. |
U.S. Appl. No. 18/265,736, filed Jun. 7, 2023. |
U.S. Appl. No. 18/299,788, filed Apr. 13, 2023. |
U.S. Appl. No. 18/335,579, filed Jun. 15, 2023. |
U.S. Appl. No. 18/373,424, filed Sep. 27, 2023. |
U.S. Appl. No. 18/376,274, filed Oct. 3, 2023. |
U.S. Appl. No. 18/548,152, filed Aug. 28, 2023. |
U.S. Appl. No. 18/549,387, filed Sep. 7, 2023. |
U.S. Appl. No. 18/549,658, filed Sep. 8, 2023. |
U.S. Appl. No. 18/553,625, filed Oct. 2, 2023. |
U.S. Appl. No. 61/955,537, filed Mar. 19, 2014. |
U.S. Appl. No. 62/082,279, filed Nov. 20, 2014. |
U.S. Appl. No. 62/084,078, filed Nov. 25, 2014. |
U.S. Appl. No. 62/414,963, filed Oct. 31, 2016. |
U.S. Appl. No. 62/485,578, filed Apr. 14, 2017. |
U.S. Appl. No. 62/853,279, filed May 28, 2019. |
U.S. Appl. No. 62/864,656, filed Jun. 21, 2019. |
U.S. Appl. No. 62/876,500, filed Jul. 19, 2019. |
U.S. Appl. No. 62/877,558, filed Jul. 23, 2019. |
U.S. Appl. No. 62/883,172, filed Aug. 6, 2019. |
U.S. Appl. No. 62/889,149 filed Aug. 20, 2019. |
U.S. Appl. No. 62/923,279, filed Oct. 18, 2019. |
U.S. Appl. No. 62/926,767, filed Oct. 28, 2019. |
U.S. Appl. No. 62/935,337, filed Nov. 14, 2019. |
U.S. Appl. No. 62/938,447, filed Nov. 21, 2019. |
U.S. Appl. No. 62/949,187 filed Dec. 17, 2019. |
U.S. Appl. No. 62/956,756, filed Jan. 3, 2020. |
U.S. Appl. No. 62/956,767, filed Jan. 3, 2020. |
U.S. Appl. No. 62/956,770, filed Jan. 3, 2020. |
U.S. Appl. No. 62/967,158, filed Jan. 26, 2020. |
U.S. Appl. No. 62/967,977, filed Jan. 30, 2020. |
U.S. Appl. No. 62/991,754, filed Mar. 19, 2020. |
U.S. Appl. No. 63/008,112, filed Apr. 10, 2020. |
U.S. Appl. No. 63/030,685, filed May 27, 2020. |
U.S. Appl. No. 63/047,374, filed Jul. 2, 2020. |
U.S. Appl. No. 63/067,542, filed Aug. 19, 2020. |
U.S. Appl. No. 63/073,545, filed Sep. 2, 2020. |
U.S. Appl. No. 63/073,553, filed Sep. 2, 2020. |
U.S. Appl. No. 63/094,498, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,646, filed Oct. 21, 2020. |
U.S. Appl. No. 63/109,066, filed Nov. 3, 2020. |
U.S. Appl. No. 63/109,084, filed Nov. 3, 2020. |
U.S. Appl. No. 63/112,417, filed Nov. 11, 2020. |
U.S. Appl. No. 63/119,161, filed Nov. 30, 2020. |
U.S. Appl. No. 63/124,271, filed Dec. 11, 2020. |
U.S. Appl. No. 63/133,892, filed Jan. 5, 2021. |
U.S. Appl. No. 63/134,287, filed Jan. 6, 2021. |
U.S. Appl. No. 63/134,450, filed Jan. 6, 2021. |
U.S. Appl. No. 63/134,631, filed Jan. 7, 2021. |
U.S. Appl. No. 63/134,632, filed Jan. 7, 2021. |
U.S. Appl. No. 63/134,754, filed Jan. 7, 2021. |
U.S. Appl. No. 63/138,878, filed Jan. 19, 2021. |
U.S. Appl. No. 63/146,946, filed Feb. 8, 2021. |
U.S. Appl. No. 63/147,013, filed Feb. 8, 2021. |
U.S. Appl. No. 63/147,299, filed Feb. 9, 2021. |
U.S. Appl. No. 63/148,723, filed Feb. 12, 2021. |
U.S. Appl. No. 63/150,640, filed Feb. 18, 2021. |
U.S. Appl. No. 63/154,248, filed Feb. 26, 2021. |
U.S. Appl. No. 63/155,395, filed Mar. 2, 2021. |
U.S. Appl. No. 63/157,007, filed Mar. 5, 2021. |
U.S. Appl. No. 63/157,014, filed Mar. 5, 2021. |
U.S. Appl. No. 63/159,142, filed Mar. 10, 2021. |
U.S. Appl. No. 63/159,186, filed Mar. 10, 2021. |
U.S. Appl. No. 63/159,210, filed Mar. 10, 2021. |
U.S. Appl. No. 63/165,273, filed Mar. 24, 2021. |
U.S. Appl. No. 63/165,384, filed Mar. 24, 2021. |
U.S. Appl. No. 63/171,165, filed Apr. 6, 2021. |
U.S. Appl. No. 63/172,975, filed Apr. 9, 2021. |
U.S. Appl. No. 63/181,695, filed Apr. 29, 2021. |
U.S. Appl. No. 63/191,558, filed May 21, 2021. |
U.S. Appl. No. 63/192,274, filed May 24, 2021. |
U.S. Appl. No. 63/192,289, filed May 24, 2021. |
U.S. Appl. No. 63/193,235, filed May 26, 2021. |
U.S. Appl. No. 63/193,406, filed May 26, 2021. |
U.S. Appl. No. 63/193,891, filed May 27, 2021. |
U.S. Appl. No. 63/208,262, filed Jun. 8, 2021. |
U.S. Appl. No. 63/214,551, filed Jun. 24, 2021. |
U.S. Appl. No. 63/214,570, filed Jun. 24, 2021. |
U.S. Appl. No. 63/215,017, filed Jun. 25, 2021. |
U.S. Appl. No. 63/228,244, filed Aug. 2, 2021. |
U.S. Appl. No. 63/228,252, filed Aug. 2, 2021. |
U.S. Appl. No. 63/228,258, filed Aug. 2, 2021. |
U.S. Appl. No. 63/230,894, filed Aug. 9, 2021. |
U.S. Appl. No. 63/230,897, filed Aug. 9, 2021. |
U.S. Appl. No. 63/238,457, filed Aug. 30, 2021. |
U.S. Appl. No. 63/238,477, filed Aug. 30, 2021. |
U.S. Appl. No. 63/241,328, filed Sep. 7, 2021. |
U.S. Appl. No. 63/241,562, filed Sep. 8, 2021. |
U.S. Appl. No. 63/241,564, filed Sep. 8, 2021. |
U.S. Appl. No. 63/241,575, filed Sep. 8, 2021. |
U.S. Appl. No. 63/246,972, filed Sep. 22, 2021. |
U.S. Appl. No. 63/247,375, filed Sep. 23, 2021. |
U.S. Appl. No. 63/247,478, filed Sep. 23, 2021. |
U.S. Appl. No. 63/247,491, filed Sep. 23, 2021. |
U.S. Appl. No. 63/299,208, filed Jan. 13, 2022. |
U.S. Appl. No. 63/308,190, filed Feb. 9, 2022. |
PureWick Corporation v. Sage Products, LLC Transcripts vol. 2, Mar. 29, 2022. |
PureWick Corporation v. Sage Products, LLC Transcripts vol. 3, Mar. 30, 2022. |
PureWick Corporation v. Sage Products, LLC Transcripts vol. 4, Mar. 31, 2022. |
PureWick Corporation v. Sage Products, LLC Transcripts vol. 5, Apr. 1, 2022. |
PureWick Corporation v. Sage Products, LLC Transcripts vol. 1, Mar. 28, 2022. |
“AMXD Control Starter Kit”, Omni Medical Systems, Inc., 1 page. |
“AMXDmax Advanced Mission Extender Device User & Maintenance Guide”, Omni Medical, Jan. 11, 2010, 10 pages. |
“AMXDmax Development History 2002-2014”, Omni Medical Systems, Inc., 2 pages. |
“Combat Force Multiplier in Flight Bladder Relief Cockpit Essential Equipment Brochure”, Omni Medical, 20 pages. |
“External Urine Management for Female Anatomy”, https://www.stryker.com/us/en/sage/products/sage-primafit.html, Jul. 2020, 4 pages. |
“GSA Price List”, Omni Medical, Apr. 2011, 2 pages. |
“High Absorbancy Cellulose Acetate Electrospun Nanofibers for Feminine Hygiene Application” , https://www.sciencedirect.com/science/article/abs/pii/S2352940716300701?via%3Dihub , Jul. 2016, 3 pages. |
“How is Polypropylene Fiber Made”, https:www.yarnsandfibers.com/textile-resources/synthetic-fibers/polypropylene-fiber/polypropylene-fiber-production-raw-materials/how-is-polypropylene-fiber-made/ last accessed 2020, Oct. 7, 2020, 3 pages. |
“Hydrogel properties of electrospun polyvinylpyrrolidone and polyvinylpyrrolidone/poly(acrylic acid) blend nanofibers”, https://pubs.rsc.org/en/content/articlelanding/2015/ra/c5ra07514a#!divAbstract, 2015, 5 pages. |
“Letter to Mark Harvie of Omni Measurement Systems”, Department of Veterans Affairs, Nov. 1, 2007, 11 pages. |
“Making Women's Sanitary Products Safer and Cheaper”, https://www.elsevier.com/connect/making-womens-sanitary-products-safer-and-cheaper, Sep. 2016, 10 pages. |
“Novel Nanofibers Make Safe and Effective Absorbent for Sanitary Products”, https://www.materialstoday.com/nanomaterials/news/nanofibers-make-safe-and-effective-absorbent/, Oct. 2016, 3 pages. |
“Revised AMXDmax Advanced Mission Extender Device User & Maintenance Guide”, Omni Medical Systems, Oct. 8, 2019, 52 pages. |
“Rising Warrior Insulated Gallon Jug Cover”, https://www.amazon.com/Rising-Warrior-Insulated-Sleeve, 2021, 2 pages. |
“Urine Bag Cover-Catheter Bag Cover 2000 ml Volume-Medline Style-Multiple Sclerosis-Spine Injury-Suprapublic Catheter-Bladder Incontinence”, https://www.etsy.com/listing/1142934658/urine-bag-cover-caatheter-bag-cover-2000, 2022, 1 page. |
“Vinyl Dust Cover, Janome #741811000, Janome, Sewing Parts Online”, https://www.sewingpartsonline.com/vinyl-dust-cover-janome-74181000, 2020, 2 pages. |
Ali, “Sustainability Assessment: Seventh Generation Diapers versus gDiapers”, The University of Vermont, Dec. 6, 2011, pp. 1-31. |
Autumn, et al., “Frictional adhesion: a new angle on gecko attachment”, The Journal of Experimental Biology, 2006, pp. 3569-3579. |
Cañas, et al. , “Effect of nano- and micro-roughness on adhesion of bioinspired micropatterned surfaces” , Acta Biomaterialia 8 , 2012, pp. 282-288. |
Chaudhary, et al., “Bioinspired dry adhesive: Poly(dimethylsiloxane) grafted with poly(2-ethylhexyl acrylate) brushes”, European Polymer Journal, 2015, pp. 432-440. |
Dai, et al., “Non-sticky and Non-slippery Biomimetic Patterned Surfaces”, Journal of Bionic Engineering, Mar. 2020, pp. 326-334. |
Espinoza-Ramirez, “Nanobiodiversity and Biomimetic Adhesives Development: From Nature to Production and Application”, Journal of Biomaterials and Nanobiotechnology, pp. 78-101, 2019. |
Hwang, et al., “Multifunctional Smart Skin Adhesive Patches for Advanced Health Care”, Adv. Healthcare Mater, 2018, pp. 1-20. |
Jagota, et al., “Adhesion, friction, and compliance of bio-mimetic and bio-inspired structured interfaces”, Materials Science and Engineering, 2011, pp. 253-292. |
Jeong, et al., “A nontransferring dry adhesive with hierarchical polymer nanohairs”, PNAS, Apr. 7, 2009, pp. 5639-5644. |
Jeong, et al., “Nanohairs and nanotubes: Efficient structural elements for gecko-inspired artificial dry adhesives”, Science Direct, 2009, pp. 335-346. |
Karp, et al., “Dry solution to a sticky problem”, Nature, 2011, pp. 42-43. |
Lee, et al., “Continuous Fabrication of Wide-Tip Microstructures for Bio-Inspired Dry Adhesives via Tip Inking Process”, Journal of Chemistry, Jan. 2, 2019, pp. 1-5. |
Merriam-Webster Dictionary, “Embed Definition & Meaning”, https://www.merriam-webster.com/dictionary/embed last accessed Aug. 3, 2023, 2003. |
Parness, et al., “A microfabricated wedge-shaped adhesive array displaying gecko-like dynamic adhesion, directionality”, J.R. Soc. Interface, 2009, pp. 1223-1232. |
Pieper, et al., “An external urine-collection device for women: A clinical trial”, Journal of ER Nursing, vol. 20, No. 2, Mar./Apr. 1993, pp. 51-55. |
Tsipenyuk, et al., “Use of biomimetic hexagonal surface texture in friction against lubricated skin”, Journal of The Royal Society—Interface, 2014, pp. 1-6. |
Vinas, “A Solution For An Awkward—But Serious—Subject”, http://www.aero-news.net/index.cfm?do=main.textpost&id=69ae2bb1-838b-4098-a7b5-7flbb2505688 last accessed Feb. 8, 2021. |
Number | Date | Country | |
---|---|---|---|
20210236323 A1 | Aug 2021 | US |
Number | Date | Country | |
---|---|---|---|
62665321 | May 2018 | US |